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The cancer diagnosis is a traumatic one for patients. Patients diagnosed 
with cancer often face significant emotional sequelæ in the form of depression 
and anxiety that may persist from post-diagnosis all the way to post-
survivorship. The prevalent cultural norms and the underutilisation of mental 
health services in Asia, coupled with the busy outpatient clinics with a focus 
on physical symptoms of cancer progression and management, have resulted 
in elevated levels of depression and anxiety amongst Asian cancer patients as 
compared to the general population. It is therefore necessary to understand the 
prevalence of patients that are at risk (subsyndromal) for such psychiatric 
disorders. Improving certain positive psychosocial resources, or innate traits, 
such as hope, optimism, resilience, mindfulness, and spirituality, can 
potentially ameliorate these elevated non-somatic symptoms of anxiety and 
depression in cancer patients. Much of the work, however, has primarily been 
conducted in the West, and no research has examined the simultaneous 
associations and predictive value of these resources on depressive and anxious 
symptoms. The present exploratory study therefore sought to address these 
lacunæ in the literature in a sample of newly diagnosed Asian cancer patients 
in Singapore: (1) determine the course of psychosocial resources; (2) 
determine the prevalence of subsyndromal anxiety and depression, and the 
course of this caseness as well as the non-somatic symptoms; (3) investigate 
the cross-sectional associations between psychosocial resources and these 
non-somatic symptoms; and (4) investigate the collective cross-sectional and 




somatic symptoms. The present study used a subset of 142 baseline patients 
diagnosed within three months from the HOPE study and investigated these 
variables at two prospective assessments at three monthly intervals. Patients 
were representative of the local cancer and general population. Study findings 
highlighted the stability of psychosocial resources as well as non-somatic 
symptoms of depression and anxiety. One in five patients suffered from 
subsyndromal depression and one in two suffered from subsyndromal anxiety 
across the year, with a third of patients suffering from persistent subsyndromal 
depression and two-thirds from persistent subsyndromal anxiety. Results also 
suggested significant bivariate associations between psychosocial resources 
and depression and anxiety scores, indicating the potential cross-cultural 
variability of these measures. Upon further investigation, it was discovered 
that of all the psychosocial components, aspects of spirituality, namely 
meaning/peace and faith were significant in influencing scores of depression 
and anxiety across time after controlling for all sociodemographic and medical 
variables. While meaning/peace was consistently protective, faith seemed to 
be detrimental at baseline, but protective in the long run. Given the elevated 
and persistent levels of subsyndromal sequelæ, future work can consider 
developing services that incorporate such components of spirituality may 
potentially be into secular brief integrative psychotherapy for use in busy 
cancer clinics with constraints on resource allocation. Future work should also 
attempt to verify these relationships in other more homogeneous Asian 
samples and ascertain if there differential patterns of associations to better 
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The human body comprises trillions of cells that constitute and assist 
everyday maintenance and function of the human body. In the course of 
natural senescence, old or damaged cells undergo a process called apoptosis, 
or programmed cell death, and are replaced by new cells. Sometimes, however, 
this natural order collapses: cells, in any part of the body, may ignore signals 
to terminate division or initiate apoptosis, forming a large mass of unneeded 
cells called a tumour (National Cancer Institute, 2015e).  
These tumours are very often malignant: they not only influence the 
surrounding normal cells to supply oxygen and nutrients via blood vessels, but 
also protect themselves from being killed by the body’s immune system. They 
also spread, or metastasise, to the rest of the body via the blood and lymph 
systems (National Cancer Institute, 2015e). Cancer is thus the umbrella term 
characterising diseases in which cells divide abnormally, without control, and 
invade nearby tissues (National Cancer Institute, 2015a).  
There are several main types of cancer (National Cancer Institute, 
2015e). Carcinoma begins in the epithelial tissues (e.g., the skin, or tissues 
lining or covering internal organs) while sarcoma begin in mesenchymal 
tissues (e.g., bone, cartilage, fat, muscle, blood vessels, or other connective or 
supportive tissue). Leukaemia begins in blood-forming tissue (e.g., bone 
marrow), whereas lymphoma and multiple myeloma begins in the immune 
system cells. Central nervous system cancers are those that originate in brain 
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and spinal cord. Prognoses for patients diagnosed with cancer are dependent 
on tumour site, maturity, and metastasis, and response to cancer treatments 
(National Cancer Institute, 2015c). 
Three of the more common forms of anticancer therapy are: 
chemotherapy, radiotherapy, and surgery (National Cancer Institute, 2015c). 
Where chemotherapy employs the assistance of drugs, radiotherapy engages 
targeted radiation, and surgery removes the tumour (or as much of it as 
possible). These therapies seek to eradicate the cancer cells, slow the 
unadulterated proliferation of healthy cells, or ease the symptoms associated 
with the tumour (e.g., pain or pressure). The efficacy of these interventions, 
however, varies widely between individuals, even those with the same site and 
stage of cancer (Andersen & Simonelli, 2007). Further, because of 
multifactorial barriers to screening (Womeodu & Bailey, 1996), cancers are 
often only detected when there are significant somatic symptoms, by which 
time prognoses are poor and more aggressive, and prolonged combined 
anticancer therapies are necessary (National Cancer Institute, 2015c).  
Cancers are only considered ‘in remission’ when the cancer signs and 
symptoms are reduced or have disappeared, and patients may potentially be 
considered ‘cured’ only if their cancers are in complete remission for five 
years or more. Even then, ‘cured’ patients require regular follow-up checks to 
ascertain the status of cancer remission (National Cancer Institute, 2015d). 
Unfortunately, for the majority of patients, cancer remains a chronic condition, 
and, despite advancements in biomedical and pharmaceutical science, cancer 
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remains, globally, one of the most feared diseases (Dein, 2004): cancer 
diagnoses are often seen as death sentences (Dein, 2004; Moser et al., 2013). 
Emotional Sequelæ of a Cancer Diagnosis  
These fatalistic reactions are understandable (Cohen, 2013): cancer is 
the leading cause of death worldwide, accounting for around 13% (7.6 million) 
of deaths in 2008, with an expected increase of almost 50% to 11 million in 
the next 15 years (World Health Organization, 2014). While there are some 
clear risk factors for the development of various cancers, cancer cells develop 
due to a complex combination of genetic (hereditary) and environmental (e.g., 
excessive smoking, drinking, etc.) interactions that often cannot be predicted 
(National Cancer Institute, 2015b). Because of its unpredictability and 
associated mortality, the cancer diagnosis, regardless of stage and site, is thus 
a traumatic and incredibly stressful experience for both patients and their 
families alike (Civilotti et al., 2015).  
Cancer patients often grapple with four concurrent crises (Costantini, 
Levenson, & Bersani, 2013). The first is the existential threat of the disease, or 
the potential for death, which may often be exacerbated by the lack of a clear 
cause for the cancer. Second, patients have to deal with the many psychosocial 
consequences that include, but are not limited to, changes in their employment 
status, family roles, and social life, which are often sudden, severe, and 
significantly debilitating. Third, patients face the physical consequences of 
disease morbidity: acute and chronic pain, associated fatigue, and other issues 
such as dyspnoea (laboured breathing). Finally, patients also have to deal with 
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the physical and perceived cognitive side effects of anticancer treatments that 
involve severe changes to diet (including nausea), appearance (e.g., alopecia 
or hair loss), and mobility (as a result of surgical mutilation). The range of 
these physical, emotional, and psychosocial threats or losses understandably 
has a deleterious effect on wellbeing indicators such as quality of life (QOL) 
or emotional adjustment (Salsman, Pearman, & Cella, 2013). 
It is thus unsurprising that cancer patients experience elevated levels of 
concomitant psychological and psychiatric sequelæ (Civilotti et al., 2015) that 
can occur at any point of the cancer journey (i.e., post-diagnosis, during active 
treatment, or post-treatment; Jacobsen & Donovan, 2011; Mitchell, Ferguson, 
Gill, Paul, & Symonds, 2013). These frequently present (Gregurek, Bras, 
Dordević, Ratković, & Brajković, 2010) as elevated levels of distress (Hamer, 
Chida, & Molloy, 2009), anxious symptomatology (Stark & House, 2000), and 
depressive symptomatology (Pasquini & Biondi, 2007).  
While distress screening has been internationally-recommended as the 
best practice for identifying such symptoms (National Comprehensive Cancer 
Network, 2007), these guidelines have not yet been adopted globally, nor 
replaced physician consultations as a basis for detection and referral for 
psychological treatment or services (Mitchell, 2015). As a result, the 
responsibility to detect such potentially harmful symptoms and manage them 
in a timely manner primarily falls on attending clinicians (e.g. physicians, 
nurses, or even social workers). Unfortunately, in public healthcare 
institutions, healthcare professionals are often limited by time restraints, with 
little or no time available for eliciting emotional symptomatology (Mitchell, 
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2015). This may lead to an underestimation of such symptoms (Passik et al., 
1998), and the tendency to ‘normalise’ such emotions as being an inevitable 
and unavoidable consequence of being diagnosed with cancer (Duffy, 2011), 
both of which exacerbate the delay in timely referral for psychological support 
services.  
These elevated symptoms are therefore oftentimes undetected, 
untreated, and the most overlooked of all cancer complications (Carr & Steel, 
2013), written off and dismissed by physicians, caregivers, and even patients 
themselves (Valentine, 2011). Consequently, these reactions often slowly 
fester into significant clinically relevant psychiatric sequelæ (Kang, Sung, 
Park, Lee, & Lee, 2014)—chiefly mood (e.g., adjustment disorders [AD], 
major depressive disorders [MDD], and mania), anxiety, and post-traumatic 
stress disorders (PTSD)—that pose a greater risk for downstream management 
(Das-Munshi et al., 2008).  
The rest of the introduction in the following thesis will present an 
overview of depression and anxiety in the context of cancer, and then proceed 
to review the more prominent personal positive psychosocial resources that 
may alleviate such symptomatology. The chapter will then delve into the 
limitations of past studies and conclude with the aims and hypotheses of the 
present thesis. 
Depression in Patients Diagnosed with Cancer 
Prevalence. The prevalence of depression in cancer patients varies 
considerably between populations (Massie, Lloyd-Williams, Irving, & Miller, 
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2011). Globally, it is estimated that between 8–33% of cancer patients meet 
the Fourth Edition of the Diagnostic and Statistical Manual (DSM-IV) criteria 
for a major depression, with many more patients misdiagnosed as suffering 
from adjustment disorders, and an even larger number of patients undiagnosed 
(Mitchell et al., 2011; Pasquini & Biondi, 2007; Valentine, 2011). This 
variation in depression is a product of various factors, including but not 
limited to, tumour prognoses (which is dependent on tumour sites, metastases, 
and stages), the effect of environmental influences on genetic predispositions 
to depression (e.g. perinatal factors, childhood experiences, etc.), and other 
sociocultural and personality issues (Pasquini & Biondi, 2007; Valentine, 
2011).  
Course. Evidence on the course and prevalence of depression across 
the cancer journey are somewhat unclear. The most recent meta-analysis 
synthesising the research on the course of depression across time has 
suggested a general stability over time (van’t Spijker, Trijsburg, & 
Duivenvoorden, 1997); however, more recent research is less definitive. Some 
has suggested that, depression levels decrease (Bergerot et al., 2015; Korfage, 
Essink-Bot, Janssens, Schröder, & de Koning, 2006; Maurer, Schäfer, Maurer, 
& Kölbl, 2012; Meraner et al., 2012) to that of the general population’s after 
one year (Schwarz et al., 2008), especially after treatment, but remain stable 
soon after (Astrup, Rustøen, Miaskowski, Paul, & Bjordal, 2015; Stafford et 
al., 2013, 2015). Others, however, have suggested that, without intervention, 
depression levels remain stable without fluctuations, elevated, and clinically 
relevant throughout (Brewin, Watson, McCarthy, Hyman, & Dayson, 1998; 
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Hopwood, Sumo, Mills, Haviland, & Bliss, 2010; Oerlemans et al., 2014; 
Thomas et al., 2014). Regardless, these levels of depression underscore a 
greater need for regular and consistent monitoring and social support. It is also 
important to note that studies that have found decreases in depression have not 
been controlled for the various sociodemographic and medical variables that 
may affect such adjustment. In addition, few of these studies have examined 
group changes in depression across time in Asian patients diagnosed with 
cancer. 
Symptoms. Typical symptoms of major depression include a 
depressed mood, appetite or weight changes, fatigue, and psychomotor 
disturbances (Koenig, George, Peterson, & Pieper, 1997). While screening for 
depressive symptoms is helpful (Passik & Lowery, 2010), it is, however, 
admittedly difficult to diagnose clinically relevant depressive disorders in 
cancer patients (Duffy, 2011). Diagnoses of major or minor depressive 
disorders, adjustment disorders, or depression due to a medical condition 
require experiences of concurrent cognitive (e.g., anhedonia [loss of interest or 
pleasure in daily activities], diminished ability to think or concentrate, 
recurrent suicidal ideation) and somatic symptoms (e.g., insomnia, fatigue, 
significant unintentional weight gain or loss) in addition to prolonged 
depressed mood. Cancer patients, unfortunately, often experience significant 
somatic (and sometimes even cognitive) side effects of both the cancer 
progression and management that overlap significantly with these diagnostic 
criteria (Valentine, 2011). Even though depressed cancer patients report 
experiencing greater somatic symptoms as compared to psychiatric controls 
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(Moorey & Steiner, 2007), diagnosis and subsequent monitoring is often 
hindered (Spoletini, Caltagirone, Ceci, Gianni, & Spalletta, 2010).  
Screening. The most commonly used self-administered questionnaires 
in screening for depression and measuring depressive symptomatology in 
psycho-oncology settings are the Hospital Anxiety and Depression Scale 
(HADS; Zigmond & Snaith, 1983), which precludes the somatic symptoms of 
depression, and Brief Symptom Inventory (BSI; Derogatis & Melisaratos, 
1983). Both questionnaires take approximately 10 minutes for patients to 
complete, and for administrators to score. One in two cancer patients classified 
as depressed on the HADS meet the DSM-IV criteria for depression (K. R. 
Beck, Tan, Lum, Lim, & Krishna, 2014; Vodermaier & Millman, 2011). 
Recently, the Distress Thermometer (DT; Roth et al., 1998), an ultra-short 
single-item screening tool has also been recommended for use with cancer 
patients because of its brevity and sensitivity both in Western (Mitchell, 2010) 
and Asian settings (H. A. Lim, Mahendran, Chua, et al., 2014). 
Management. The management of depressive disorders in patients 
with comorbid chronic physical diseases like cancer thus target the alleviation 
of non-somatic (cognitive) symptoms of depression (National Collaborating 
Centre for Mental Health (UK), 2010). This is often done through the 
concomitant use pharmacotherapy and psychotherapy (Akechi, 2012), with 
protocols adjusted based on clinimetric (vs. psychometric) evaluations (Satin, 
Linden, & Phillips, 2009).  
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Pharmacological interventions. While the various classes of 
antidepressants are often well tolerated in ambulatory cancer patients (Grassi, 
Nanni, Uchitomi, & Riba, 2010), pharmacological treatment often takes time 
to show efficacy, and may themselves contribute to some unwanted somatic 
side effects (Valentine, 2011). In fact, a recent meta-analysis has suggested 
that the use of antidepressants to treat depressive symptomatology in cancer 
patients were not significantly more effective than placebos (Ostuzzi, 
Matcham, Dauchy, Barbui, & Hotopf, 2015).  
Psychological interventions. As such, the various forms of supportive 
psychotherapy or psychological interventions (e.g. cognitive behavioural 
therapy, group therapy, or psychoeducation) have been recommended as key 
in effective in alleviating depressive symptoms in both psychiatric (National 
Collaborating Centre for Mental Health, 2010) and cancer-comorbid patients 
(Kissane, Levin, Hales, Lo, & Rodin, 2010). While cancer patients are often 
overwhelmed and fatigued from anticancer therapy to regularly attend a 
prescribed course of psychotherapy (Valentine, 2011), a recent meta-analysis 
concluded that brief supportive nurse-led interventions for newly diagnosed 
cancer patients (e.g., Mahendran, Lim, Tan, Chua, et al., 2015) yielded 
reductions in depressive symptoms (Galway et al., 2012). Reviews have also 
suggested that traditional clinician-led psychotherapy has been shown to 
improve depressive symptomatology (but not clinical diagnoses) in advanced 
(Akechi, 2012) and incurable cancer patients (Akechi, Okuyama, Onishi, 
Morita, & Furukawa, 2008), with such improvements also documented for 
cancer survivors (Osborn, Demoncada, & Feuerstein, 2006). 
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Consequences. Research has overwhelmingly underscored the 
devastating consequences of depression in cancer patients (Kissane & 
Doolittle, 2013). Depression in cancer patients has been shown to be 
associated to a deteriorating QOL and poorer adjustment (M. R. Visser & 
Smets, 1998). It has also been shown to confer an independent risk for poor 
clinical outcomes such as increased mortality (Breitbart, Pessin, & Kolva, 
2010). This may occur through biobehavioural interactions (via the 
psychoneuroimmunological pathways involving proinflammatory cytokines; 
Pasquini & Biondi, 2007) and less optimistic prognoses (Satin et al., 2009), 
and lower adherence to prescribed anticancer therapy (DiMatteo & Haskard-
Zolneirek, 2011). It may also occur through acting upon suicidal ideation 
(Massie, Gagnon, & Holland, 1994) because of feelings of hopelessness, 
helplessness, and perceived QOL deterioration (Costantini et al., 2013); in the 
United States, the rate of suicides amongst cancer patients are twice that of the 
general population (Misono, Weiss, Fann, Redman, & Yueh, 2008). Mortality 
due to suicide is especially pertinent in the first 30–100 days following a 
diagnosis (Johnson, Garlow, Brawley, & Master, 2012) in which cancer 
patients’ existential plight is most significant (Weisman & Worden, 1976).  
Anxiety in Patients Diagnosed with Cancer  
Prevalence. Elevated levels of anxiety are seen in one in two newly 
diagnosed patients (Sheldon, Swanson, Dolce, Marsh, & Summers, 2008; 
van’t Spijker et al., 1997). Globally, it is estimated that between 10–16% meet 
the DSM-IV or 10th Edition of the International Classification of Diseases 
(ICD-10) criteria for general anxiety disorder, with another 3–19% meeting 
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the criteria for post-traumatic stress disorder (Mitchell et al., 2011; Rashid, 
2011; Steinman, 2009). This variation in anxiety, like depression, is a product 
of the interaction between medical variables (e.g., tumour characteristics), 
early-life traumas (e.g., physical or sexual abuse), and other sociocultural (e.g., 
tendency for emotional suppression or expression) and personality issues (e.g., 
anxious-type personality) that may predispose or influence coping styles and 
responses to stress (Rashid, 2011).  
Course. Evidence on the course and prevalence of anxiety across the 
cancer journey are somewhat unclear. The most recent meta-analysis 
synthesising the research on the course of anxiety across time has suggested a 
general decrease over time (van’t Spijker et al., 1997); however, more recent 
research is less definitive. Some has suggested that, without intervention, 
anxiety levels remain stable, elevated, and clinically relevant (Brewin et al., 
1998; Jacobsen & Donovan, 2011; Oerlemans et al., 2014; Schwarz et al., 
2008; Thomas et al., 2014), even up to five-year post-diagnosis (Hopwood et 
al., 2010). Others suggest still that levels of anxiety decrease significantly 
post-treatment (Bergerot et al., 2015; Korfage et al., 2006; Maurer et al., 2012; 
Meraner et al., 2012), or if they decrease post-diagnosis, they remain stable 
throughout the next two years (Stafford et al., 2013, 2015). Regardless, the 
high or fluctuating levels of anxiety underscore a greater need for constant and 
consistent monitoring and social support. It is also important to note that 
studies that have found decreases in anxiety have not been controlled for the 
various sociodemographic and medical variables that may affect such 
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adjustment. In addition, few of these studies have examined group changes in 
anxiety across time in Asian patients diagnosed with cancer. 
Symptoms. Typical symptoms of anxiety include feelings of 
uncertainty, helplessness, and inadequacy, and are also expressed somatically 
in sweaty palms, increased heart rate, irregular breathing, and dryness in the 
throat (Endler, Parker, Bagby, & Cox, 1991). Screening for anxious symptoms 
is helpful (Passik & Lowery, 2010), but it is admittedly difficult to diagnose 
clinically relevant anxiety disorders in cancer patients because of the constant 
need to re-evaluate and separate the organic anxiety (i.e., biochemical or 
pharmacological causes of anxious symptomatology) from the functional 
anxiety (i.e., anxiety as a result of facing various crises associated with the 
disease) throughout the cancer journey (Rashid, 2011). Further, identifying 
abnormal levels of anxiety is also somewhat difficult given that normal levels 
of anxiety fluctuate in cancer patients from diagnosis onwards (Stark & House, 
2000). In addition, the criteria for diagnoses of anxiety-related disorders (e.g., 
phobias, panic disorders, anxious adjustment disorder, and generalised anxiety 
disorder) includes concurrent somatic symptomatology; in cancer patients, 
these somatic symptomatology, however, often overlap significantly with 
patients’ own cancer-related therapy and disease progression (Rashid, 2011; 
Stark & House, 2000).  
Screening. The most commonly used self-administered questionnaires 
in screening for depression and measuring depressive symptomatology in 
psycho-oncology settings are the Hospital Anxiety and Depression Scale 
(HADS; Zigmond & Snaith, 1983) and State–Trait Anxiety Inventory (STAI; 
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Spielberger, 1983). Both questionnaires take approximately 10 minutes for 
patients to complete, and for administrators to score. Four in ten cancer 
patients classified as depressed on these scales meet the DSM-IV criteria for 
anxiety (K. R. Beck et al., 2014; Vodermaier & Millman, 2011). Recently, the 
Distress Thermometer (DT; Roth et al., 1998) has also been recommended for 
use with cancer patients because of its brevity and sensitivity both in Western 
(Mitchell, 2010) and Asian settings (H. A. Lim, Mahendran, Chua, et al., 
2014).  
Management. The management of anxiety disorders in patients with 
comorbid chronic physical diseases such as cancer thus target the alleviation 
of non-somatic (cognitive) symptoms of anxiety (Jacobsen, Donovan, Swaine, 
& Watson, 2006). This is often done through the concomitant use 
pharmacotherapy and psychotherapy (National Comprehensive Cancer 
Network, 2007; Sheldon et al., 2008), and because of the unique causes and 
nature of anxiety, management heavily relies on clinimetric (vs. psychometric) 
evaluations (Jacobsen et al., 2006; Rashid, 2011).  
Pharmacological interventions. The various classes of antidepressants, 
(the off-label use of) antipsychotics, and various antihistamines are often well 
tolerated in ambulatory cancer patients (Jacobsen et al., 2006; Rashid, 2011). 
Pharmacological treatment, however, often takes time to show efficacy, and 
may themselves contribute to some unwanted somatic side effects (e.g., 
lowered sex drive, gastrointestinal discomfort, akathisia, etc.; Rashid, 2011).  
  
14 
Psychological interventions. The various forms of supportive 
psychotherapy (e.g. cognitive behavioural therapy, group therapy, or 
psychoeducation) are thus recommended in alleviating anxious symptoms in 
patients diagnosed with cancer (Jacobsen et al., 2006; Rashid, 2011; Roth & 
Massie, 2007). Cancer patients, however, are often overwhelmed and fatigued 
from anticancer therapy to regularly attend a prescribed course of 
psychotherapy (Sheldon et al., 2008; Valentine, 2011). Despite this, a recent 
meta-analysis has suggested that newly diagnosed cancer patients who attend 
brief supportive nurse-led interventions (e.g., Mahendran, Lim, Tan, Chua, et 
al., 2015) experience the ameliorating or reduction in distress and even 
anxious symptoms (Galway et al., 2012).  
Consequences. Research has overwhelmingly underscored the 
devastating consequences of anxiety in cancer patients (Stark et al., 2002). 
Anxiety disorders have a negative effect on the QOL of cancer patients 
(Sareen et al., 2006; Stark et al., 2002), lead to impairments in not only social 
but also physical functioning (e.g., fatigue; Brown & Kroenke, 2009), and 
may also exacerbate the perceived severity of the physical side-effects of 
treatment (Stark & House, 2000). Anxiety resulting from the cancer may also 
impair help-seeking behaviours in cancer survivors for future cancer screening 
(Consedine, Magai, Krivoshekova, Ryzewicz, & Neugut, 2004), medication 
adherence (Theofilou & Panagiotaki, 2012) and even result in termination or 
discontinuation of treatment (Moadel & Harris, 2008). Anxiety in cancer 
patients often co-occur with depressive symptoms and may thus potentially 
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exacerbate depressive symptoms and increase suicidal ideation (Massie et al., 
1994). 
Depression and Anxiety in Asian Patients Diagnosed with Cancer  
Unfortunately, these psychopathological reactions to cancer are 
perhaps of even greater concern amongst Asian cancer patients who report 
fewer help-seeking behaviours and intentions for cancer-related treatments 
(Gany, Herrera, Avallone, & Changrani, 2006), much less treatment for 
associated psychological sequelæ (B. S. K. Kim & Omizo, 2003). Asian-
migrant or Asian-minority cancer patients report elevated levels of depression 
and anxiety as compared to their non-Asian counterparts (Pasquini & Biondi, 
2007). While the prevalence of depression and anxiety in Western societies 
are no different in those with cancer (van’t Spijker et al., 1997), cancer 
patients in Asia report higher rates of depression and anxiety as compared to 
the general population (Yang et al., 2013).  
In Singapore, an island-state in Southeast Asia with a population of 5.3 
million, 10% of cancer inpatients were found to have generalised anxiety 
disorder, while 17% had major depression (S. M. Tan, Beck, Li, Lim, & 
Krishna, 2014), three to ten times that of the local population (Chong et al., 
2012). Three in twenty outpatients (15–16%) reported experiencing significant 
levels of subsyndromal anxiety and depression at the first oncologist visit for 
treatment planning (H. A. Lim, Mahendran, Chua, et al., 2014), and four in 
five newly diagnosed cancer outpatients reported at least one unmet emotional 
concern (Mahendran, Lim, Chua, Lim, & Kua, 2015).  
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The increased prevalence of psychopathology amongst Asians may 
potentially be a result of how oncology clinics in Asia often become the 
victims of newly developed or developing nations, where the primary focus of 
public healthcare is on reducing the incidence and mortality associated with 
somatic as compared to psychological sequelæ of cancer (Grassi & Watson, 
2012). Coupled with this is the cultural tendency for Asians to somatise such 
sequelæ (Bailey et al., 2005) till they become clinically relevant (Taillefer, 
Kirmayer, Robbins, & Lasry, 2003), which further complicate diagnosis 
because these are often undistinguishable from the known somatic side effects 
of anticancer treatments (Andersen & Simonelli, 2007).  
This elevated symptomatology in Asians is worrying, given the rising 
incidence of cancer amongst Asians in today’s globalised multi-cultural 
society (Grassi, Caruso, Sabato, Massarenti, & Nanni, 2015). In Singapore, 
there was a 14% increase in new cancer cases between 2008–2012 (National 
Registry of Diseases Office, 2012), which paralleled the growing cancer 
incidence rates amongst the increasing numbers of Asian immigrants and 
minority communities worldwide (Chen, Jr., 2005), where one in two incident 
cancer patients is Asian (World Health Organization, 2014). In addition, lower 
screening rates are reported amongst Asians and minority Asian ethnic groups 
in predominantly non-Asian societies (McDonald & Kennedy, 2007).  
Positive Psychosocial Resources in Patients Diagnosed with Cancer 
It is therefore imperative to identify and treat depressed and anxious 
cancer patients early in the cancer journey (Aziz & Rowland, 2002) for whom 
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a focus on the non-somatic subsyndromal symptomatology remains clinically 
present, relevant, and potential targets for amelioration (Andersen et al., 2014).  
The pathological emotional reactions to cancer are dependent on a 
complex interplay of medical (e.g., cancer stage, site, and maturity), 
socioeconomic (e.g., ability to access and receive quality cancer care), 
interpersonal (social/family support and caregiving), and intrapersonal factors 
(Costantini et al., 2013). While medical, socioeconomic, and interpersonal 
factors lie outside of patients’ loci of control, intrapersonal factors, on the 
other hand are well within the grasp of both patients and clinicians (Moadel & 
Harris, 2008).  
Based on models of stress and coping (Folkman, 2013), patients’ 
intrapersonal resources are often conceived as innate traits that influence 
appraisals and moderate patients’ pathological emotional reactions to the 
cancer diagnosis (Costantini et al., 2013). These positive psychological 
variables, such as hope, optimism, resilience, mindfulness, and spirituality 
(Pitceathly, Watson, & Cawthorn, 2013), may lend themselves to patients’ 
coping with the diagnosis (Jacobsen et al., 2006) and potentially improve 
wellbeing and mortality (Chida, Hamer, Wardle, & Steptoe, 2008; Chida & 
Steptoe, 2008). These intrapersonal resources are thus often the targets of 
cognitive therapies (Clark & Beck, 2010) and psychosocial interventions 
(Watson, 2012) for cancer patients who respond poorly to 




Hope in Patients Diagnosed with Cancer 
Definition. Hope has long been identified as an important therapeutic 
factor in medicine and recovery (Farran, Herth, & Popovich, 1995; Schrank, 
Stanghellini, & Slade, 2008), enabling individuals to deal with serious and 
prolonged threats to their physical and psychological wellbeing (Olver, 2012). 
There exist many definitions of hope across the various fields of inquiry 
(Eliott & Olver, 2002). The psychological and psychiatric literature have 
defined hope as a yearning for the amelioration of a dreaded outcome, which 
may be operationalised as both a positive goal-related (future-oriented) 
motivational state, and a dispositional trait signalling a tendency to adopt a 
positive outlook (Folkman, 2013; Schrank et al., 2008). In other words, hope 
is a confident, yet uncertain, expectation of achieving a future good, that, to 
the hoping person, is realistically possible, and personally significant (Herth, 
1992).  
Theories. Dispositional theories of hope have suggested that there are 
two components of hopeful thinking (Snyder, 2002): pathway thinking, or the 
ability to conceptualise the means (pathways) through which goals can be 
achieved; and agency thinking, or the perceived capacity to use such pathways. 
While hope has often been linked to other positive motivational theories, it 
remains distinct from optimism in its view of goal-directed positive cognitive 
processes, and self-efficacy in its cross-situational perspective and equal 
emphasis on both agency and pathway thinking (Snyder, 1995). Higher levels 
of these two components of thinking (agency and pathway) have been shown 
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to correlate with fewer symptoms of depression and anxiety (Gil & Gilbar, 
2001; Snyder, 2002). 
Oncology settings. In oncology settings, hope facilitates both patients’ 
and caregivers’ coping with the cancer diagnosis (Clayton, Butow, Arnold, & 
Tattersall, 2005), allowing patients to make and sustain meaning in their lives 
(Folkman, 2013) and strengthening and supporting resilience regardless of 
prognosis (Gilbert, 2011). While hope has not specifically been shown to 
improve prognosis (Petticrew, Bell, & Hunter, 2002), patients without hope 
(i.e., hopeless), are often despaired, depressed, and ultimately lose the will to 
live (Farran et al., 1995). Hopeful cancer patients have generally been found to 
have better physical and psychological health and wellbeing, QOL, and 
general positive affect (Butt, 2011; Olver, 2012). 
To date, three literature reviews have examined hope in cancer patients 
(Butt, 2011; Chi, 2007; Olver, 2012). The first was a review of 26 research 
articles published between 1982–2005 that sought to summarise the 
importance of hope to nurses (Chi, 2007). While there was no clear 
sociodemographic predictors of hope, there was sufficient evidence to suggest 
that the levels of hope did not vary significantly by cancer type and stage, and 
were positively correlated with levels of control, coping, and spiritual 
wellbeing. The second review, which sought to provide the state of the nursing 
literature between 2005–2009 in relation to hope in adults with cancer (Butt, 
2011), corroborated these findings: hope was also found to improve positive 
affect and reduce depressive and anxious symptomatology. The final review 
updated the literature on hope in oncology to 2011, and included studies on 
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hope from the perspective of caregivers and family members, and healthcare 
professionals (Olver, 2012). This review verified the findings of the previous 
reviews and further suggested that hope reduced the impact of psychological 
distress and fatigue on cancer patients.  
Across these three reviews, however, only five unique articles were 
related to Asian cancer patients. These articles detailed that patients who were 
told about their diagnosis had higher levels of hope (C.-C. Lin & Tsay, 2005; 
C.-C. Lin et al., 2003), hope was not a function of disease state (Chen, 2003), 
and that hope facilitated their psychosocial adjustment (Lee, 2001), perhaps 
through feeling supported both emotionally and spiritually (Hong & Ow, 
2007). Because the effect of hope in Asian cancer patients, especially on 
depression and anxiety, are largely under-researched, or more likely, 
underrepresented, a more in-depth systematic review examining the 
biopsychosocial predictors and effects of hope in Asian cancer patients was 
recently conducted across even more databases (PubMed, CINAHL, 
PsycINFO, and Scopus) without any language or date restrictions and with 
non-English articles translated. The protocol (International Prospective 
Register of Systematic Reviews [PROSPERO] Registration: 
CRD42015014522; H. A. Lim, Yee, Griva, & Mahendran, 2015) and 
preliminary results have been described elsewhere (J. Y. S. Tan, Yee, Lim, & 
Mahendran, 2015).  
This recent review on hope in Asian cancer patients found 68 articles, 
out of which two-thirds (n = 45) were examined hope in relation to other 
psychological and psychiatric variables (J. Y. S. Tan et al., 2015). Consistent 
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with earlier findings on hope in Western contexts, this review found that levels 
of hope (or its analogue, hopelessness) was significantly associated with 
depression and anxiety (Guan et al., 2009; Y. Han et al., 2013; Ho, Fung, 
Chan, Watson, & Tsui, 2003; Hou, Law, Yin, & Fu, 2010; Kang et al., 2008; 
Rajandram et al., 2011; Shimizu et al., 2012; Uchitomi, Akechi, Fujimori, 
Okamura, & Ooba, 2003; Yang, Liu, Wang, Wang, & Wang, 2014; Yuen, Ho, 
& Chan, 2014); higher levels of hope were related to fewer symptoms of 
anxiety and depression. In fact, controlling for other demographic and clinical 
confounds, hope independently accounted significantly for 31–38% of the 
variance in depression and anxiety in Chinese cancer patients (Yang et al., 
2014). These findings suggest that the effects of hope are independent of other 
psychological coping resources like optimism, although its causality is 
uncertain. Further, given that the sample population was not limited to newly 
diagnosed individuals, however, it is also uncertain if hope fluctuates across 
time. 
The review also surfaced articles describing interventions that were 
found to be associated with improved levels of hope, among which only one 
specifically targeted at improving hope per se in Asian cancer patients (Liao, 
Yeh, Lee, & Wu, 2014), suggesting that a six-week spiritual reminiscence 
therapy intervention improved post-intervention hope scores, but were not 
sustained after six months; another suggested that culturally specific mind–
body–spirit therapy significantly reduced emotional distress through 
improvements in hope (Liu et al., 2008). Collectively, these findings bring into 
question, or perhaps further reify, the dispositional nature of hope, and suggest 
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that, while transient, improvements in the components of hope, in tandem with 
other positive psychosocial resources in various therapies (Schrank, Bird, 
Rudnick, & Slade, 2012), facilitate reductions in emotional distress. 
Optimism in Patients Diagnosed with Cancer 
Definition. While hope focuses on the personal attainment of specific 
goals, optimism focuses broadly on the expected quality of future outcomes in 
general (Bryant & Cvengros, 2004). Optimism is often defined as the 
expectation of positive outcomes (Carver, Scheier, & Weintraub, 1989), or the 
tendency to believe that good rather than bad things will happen (Scheier & 
Carver, 1992) or even as the tendency to distance oneself from negative 
outcomes (Snyder, 1995).  
Theories. There are a number of theories of optimism but all of them 
generally conceive of an optimism–pessimism continuum (Andersson, 1996), 
an inherently cognitive personality trait (Segerstrom, 2000) that is distinct 
from other related traits like neuroticism, extraversion, anxiety, self-mastery 
and self-esteem (Scheier, Carver, & Bridges, 1994). Although there is still no 
clear consensus as to the genetic and social mechanisms through which 
optimism is transmitted (Carver & Scheier, 2014), optimism has been 
identified as an important therapeutic factor in coping with health-related 
threats to individuals’ physical and psychological wellbeing (Carver & Scheier, 
2014), with higher levels of optimism are linked to fewer symptoms of 
depression and anxiety (Carver & Scheier, 2014). 
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Oncology settings. In oncology settings, optimism allows cancer 
patients to have positive expectancies about their disease, which facilitate their 
adjustment with (Carver et al., 1993), and management of (Trunzo & Pinto, 
2003), their diagnosis. While optimism has not been definitively linked to 
prognoses in cancer patients, it may facilitate other life-preserving 
mechanisms (e.g., medication adherence, lifestyle changes; more effective 
planning; Carver & Scheier, 2014; Gonzalez, 2012). Optimistic cancer 
patients thus often report better physical and psychological wellbeing (Scheier 
& Carver, 1992); pessimistic cancer patients often report delays in help-
seeking and screening, and subsequent higher rates of mortality (Gonzalez, 
2012). 
Literature on the effect of optimism in Asian cancer patients, 
especially on depression and anxiety, however, has not yet been synthesised, 
perhaps because of the enormity of the literature on optimism in cancer 
patients. Only one non-rigorous narrative review pertaining to the role of 
oncology nurses in improve optimism in cancer patients was found (Gonzalez, 
2012), but there was nary a reference to any non-Western articles. As such, a 
systematic review on optimism in cancer patients has not previously been 
conducted. Accordingly, a systematic review on the biopsychosocial correlates 
of optimism in cancer patients was conducted across a range of databases 
(PubMed, CINAHL, PsycINFO, Scopus, and Proquest) without any language 
or date restrictions. The protocol (PROSPERO Registration: 
CRD42015016658; H. A. Lim, Tan, Tan, Griva, & Mahendran, 2015) and 
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preliminary results have been described elsewhere (Z. M. Tan, Tan, Lim, & 
Mahendran, 2015). 
This recent review found 42 articles that examined the effect of 
optimism on depression and anxiety, out of which five were from Asia (Korea, 
China, and Hong Kong) and available in English (Ha & Cho, 2014; W. W. T. 
Lam et al., 2013; W. W. T. Lam, Shing, Bonanno, Mancini, & Fielding, 2012; 
Rajandram et al., 2011; Yang et al., 2014). Similar to general findings in the 
West (Gonzalez, 2012), optimism in Asian cancer patients were negatively 
correlated with symptoms of depression and anxiety (Ha & Cho, 2014; 
Rajandram et al., 2011; Yang et al., 2014). When considered with other 
sociodemographic and medical variables, however, one article suggested that 
relationships were not significant (W. W. T. Lam et al., 2012), while another 
suggested that they maintained significance and accounted for an additional 19% 
of variance in depression and anxiety scores over and above other 
psychosocial resources like hope (Yang et al., 2014). Causality regarding 
optimism is still undetermined. 
This review also highlighted that literature on both Asian and Western 
cancer patients pertaining to the course of optimism across time was still 
undecided, with a number of articles using baseline optimism for comparisons 
of longitudinal effects. In addition, the review surfaced the paucity of articles 
related to testing the efficacy of optimism-based interventions, although much 
research even in Asian cancer patients have suggested that coping styles 
influence dispositional optimism, which then influence wellbeing (Hou et al., 
2010). In other contexts, optimism-based interventions are argued to be 
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integrated and inherent in cognitive-based therapies for conditions such as 
depression (A. T. Beck, Weissman, Lester, & Trexler, 1974). Collectively, 
these findings suggest that optimism may be improved by brief interventions, 
and accounted for by other sociodemographic variables, but may not be 
maintained without consistent boosters.  
Resilience in Patients Diagnosed with Cancer 
Definition. Another positive psychological resource that has shown to 
improve medical outcomes is that of resilience (Stewart & Yuen, 2011). 
Although there exist many differing definitions (Glantz & Johnson, 2002), 
psychological resilience refers broadly to the capacity of an individual to 
thrive in the face of adversity (Connor & Davidson, 2003; Kua, Lim, & Ho, 
2015). It is often conceptualised as an innate resource, trait, or ability to not 
only withstand disruptive life challenges (Walsh, 2003), but also dynamically 
adapt to it upon encountering stressors and maintain stability in spite of 
circumstances (Luthar, Cicchetti, & Becker, 2000).  
Theories. It has been argued that resilience may include elements of 
hope, optimism, and meaning-making (Gilbert, 2011), although research has 
also argued that they remain distinct constructs (Glantz & Johnson, 2002). In 
addition, some have suggested that resilience also encompasses socio-
community resources and supportive relationships, which serve to augment 
such intrapersonal psychological resilience with interpersonal resilience 
(Kumpfer, 2002). Resilient individuals are thus better able to deal with various 
life adversities (Fletcher & Sarkar, 2013), including their physical illnesses 
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(Stewart & Yuen, 2011), sometimes even thriving on these experienced 
pressures (Fletcher & Sarkar, 2013). 
Oncology settings. In oncology patients, psychological resilience is 
associated with better adaptation to the cancer diagnosis (Carver et al., 2005), 
buffering the emotional impact and distress of the diagnosis (Sharpley, 
Wootten, Bitsika, & Christie, 2013) and facilitating post-traumatic growth 
(Molina et al., 2014). Resilient cancer patients experience less fatigue, 
improved QOL, and better wellbeing (Eicher, Matzka, Dubey, & White, 2015; 
Y.-L. Wen, Wen, Wang, & Chen, 2013). Resilience in cancer patients has also 
been associated with improved treatment adherence and thus survival (Eicher 
et al., 2015). It is unsurprising that resilient cancer patients experience fewer 
symptoms of depression and anxiety (Eicher et al., 2015; Molina et al., 2014). 
To date, two recent literature reviews have examined resilience in the 
context of cancer patients (Eicher et al., 2015; Molina et al., 2014). Both 
reviews synthesised information from the academic literature relevant to 
nursing. The first sought to describe resilience and its correlates across the 
cancer continuum by collating articles published in English between 1993–
2014 in medical and psychological databases, and found that resilience varied 
with baseline sociodemographic characteristics as well as personal 
psychosocial resources, but is a critical element of psychosocial care, 
facilitating growth, QOL, and positive medical experiences (Molina et al., 
2014). The second repeated the search a year later but included the nursing 
database and focused solely on quantitative research, suggesting that resilience 
could be facilitated by nursing interventions, but there was a paucity of work 
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in the area (Eicher et al., 2015). Both reviews also found that although 
evidence was lacking, the course of resilience in cancer patients were 
generally assumed to be stable. 
Across these two reviews, however, only five unique articles were 
related to Asian cancer patients’ resilience. These articles detailed that, similar 
to Western studies, resilience was positive associated with optimism (Hou et 
al., 2010) and hope (Ho, Ho, Bonanno, Chu, & Chan, 2010), and negatively 
associated with fatigue (Tian & Hong, 2013) and emotional distress after 
controlling for basic sociodemographics and perceived social support (W. W. 
T. Lam et al., 2012; Min et al., 2013). Much, however, is still unknown on the 
impact of resilience in Asian cancer patients’ symptoms of depression and 
anxiety, and the course of this resilience. As such, a more in-depth systematic 
review examining the biopsychosocial predictors and effects of resilience in 
Asian cancer patients was recently conducted across even more databases 
(PubMed, CINAHL, PsycINFO, Scopus, and ProQuest) without any language 
or date restrictions and with non-English articles translated. The protocol 
(PROSPERO Registration CRD42015016654; H. A. Lim, Ng, Tan, Griva, & 
Mahendran, 2015) and preliminary results have been described elsewhere (H. 
M. Ng, Tan, Lim, & Mahendran, 2015). 
This review on resilience in Asian cancer patients found 11 articles, 
half of which examined hope in relation to other psychological and psychiatric 
variables, with four being unique additions (H. M. Ng et al., 2015). Consistent 
with earlier findings on resilience in Western contexts, East Asian cancer 
patients with lower levels of resilience had greater emotional discomfort (Cha 
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& Kim, 2012) and distress (Tian & Hong, 2014), and had more symptoms of 
depression and anxiety (J. I. Kim & Byeon, 2013).  
There is still, however, a paucity of research verifying these results in 
an Asian context. Further, despite suggestions by both Asian and Western 
oncology nurses as to the effectiveness of resilience therapy in cancer patients 
(Molina et al., 2014; Y.-L. Wen et al., 2013), the lack of interventions also 
make causality regarding resilience in Asian cancer patients difficult to 
determine. In addition, the course of resilience across time was also under 
researched, echoing earlier calls for greater research to be done in this area 
(Eicher et al., 2015). Past reviews has identified a number of resilience-based 
programs that should be targeted at specific phases along the cancer 
continuum (Molina et al., 2014), with suggestions that earlier interventions 
post-diagnosis may lead to better outcomes (Eicher et al., 2015).  
Mindfulness in Patients Diagnosed with Cancer 
Definitions. While mindfulness has been promoted for centuries by 
Zen Buddhism, the Western concept of mindfulness is a more recent 
phenomenon that has grown significantly in the past four decades (Smith, 
Richardson, Hoffman, & Pilkington, 2005) and has been applied extensively 
in health settings (Keng, Smoski, & Robins, 2011) through various treatment 
modalities (Garland, Gaylord, & Fredrickson, 2011; Paloutzian & Park, 2005). 
The Western secular conceptualisation of mindfulness is often characterised as 
a purposeful, yet non-judgemental awareness, in the present moment (Kabat-
Zinn, 2003), an innate trait that can be cultivated with the regular practice of 
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certain attentional or relaxation exercises (Greene, Philip, Poppito, & Schnur, 
2012).  
Theories. There exist numerous theories about the Western 
conceptualisation of mindfulness, all of which agree that mindfulness as a 
construct is multi-faceted (Chambers, Gullone, & Allen, 2009; Kabat-Zinn, 
2003). Psychometric and factor analytic attempts at defining the various 
aspects of mindfulness have suggested that it consists, very broadly of the 
following dimensional abilities (Baer, Smith, Hopkins, Krietemeyer, & Toney, 
2006; Christopher, Neuser, Michael, & Baitmangalkar, 2012): observing and 
describing internal and external stimuli; acting with awareness and living 
moment-to-moment; non-judgemental awareness of feelings, thoughts, and 
bodily sensations; and non-reactivity to internal and external stimuli (i.e., 
‘Zen’). 
Oncology settings. In oncology settings, mindfulness, especially 
through the various mindfulness-based interventions, allows patients to 
develop a more holistic outlook on their present situation by assisting them to 
calmly reflect and appreciate their existence (Shennan, Payne, & Fenlon, 
2011). This reflection or insight results in greater emotional tolerance and 
acceptance of bodily sensations and discomfort, and is often facilitated by 
exercises (e.g., deep breathing) that also have the concurrent effect of reducing 
symptoms of anxiety and depression (Piet, Würtzen, & Zachariae, 2012) 
through increases in the parasympathetic nervous system and simultaneous 
relaxation and emotional regulation (Arch & Craske, 2006). Mindfulness in 
cancer patients thus allows them to be less reactive to the physical and 
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emotional sequelæ of their diagnosis (Foley, Baillie, Huxter, Price, & Sinclair, 
2010; Speca, Carlson, Goodey, & Angen, 2000). As such, mindful cancer 
patients are often found to have better physical and psychological health 
(Greene et al., 2012; Piet et al., 2012), QOL (Keng et al., 2011; Zainal, Booth, 
& Huppert, 2013), and existential wellbeing (Baer et al., 2008, 2006). 
A number of published reviews and meta-analyses to date have 
examined the efficacy of mindfulness-based interventions on symptoms of 
emotional distress in cancer patients (Greene et al., 2012; Shennan et al., 2011; 
Zainal et al., 2013). Most of these articles, however, failed to measure if 
improvements in emotional distress were a result of improvements in 
mindfulness per se and not other extraneous factors such as facilitated 
supportive care leading to improvements perceived social support, or 
relaxation exercises. Further, while the effect of mindfulness on physical and 
psychological health has been synthesised elsewhere (Keng et al., 2011), little 
is known if these relationships still remained significant in cancer patients. As 
such, a systematic review examining the relationships between trait 
mindfulness and depression and anxiety was conducted across relevant 
databases (PubMed, CINAHL, PsycINFO, Scopus, Web of Science) without 
any date or language restrictions.  
This review on trait mindfulness in patients diagnosed with cancer 
highlighted 12 unique articles verified earlier general postulations and findings. 
Mindful cancer patients reported improvements in emotion regulation and 
mood (Tamagawa et al., 2013), and reductions in fatigue and symptoms of 
depression and anxiety (Eyles et al., 2014), with some even suggesting the 
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physiological effects such as salivary cortisol reductions (Garland, Beck, 
Lipschitz, & Nakamura, 2015) and increased telomerase activity (Lengacher et 
al., 2014).  
It is, however, interesting to note that none of these four reviews 
surfaced any work that was done on Asian cancer patients. Past work has 
suggested that universality of mindfulness at least between Asian migrants 
(chiefly Asian Americans) and Western samples of the general population 
(e.g., Masuda, Wendell, Chou, & Feinstein, 2010). Past work has also 
suggested that components of mindfulness therapies may be relevant in 
treating East Asian migrants with mental health issues (e.g., Hall, Hong, Zane, 
& Meyer, 2011). The dearth of the efficacy of mindfulness therapies in Asian 
patients diagnosed with cancer, or even the relationships between trait 
mindfulness and emotional distress, may reflect either a publication bias or a 
lack of focus or interest in the area. Regardless, more work is still necessary to 
ascertain the relationship between trait mindfulness and symptoms of 
depression and anxiety in Asian cancer patients. 
Spirituality in Patients Diagnosed with Cancer 
Definition. Religion and spirituality has long been identified as key 
modalities to address both physical and mental health ailments (Büssing et al., 
2014; Koenig, 2012). While there exists much debate over the definition of 
spirituality, it is often defined as the experiences associated with a personal 
search for meaning and purpose in life, and the connection with (or the search 
and discovery of) a transcendent dimension of existence (Chiu, Emblen, Van 
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Hofwegen, Sawatzky, & Meyerhoff, 2004; Koenig, 2012; A. Visser, Garssen, 
& Vingerhoets, 2010). Religion, on the other hand, is an organised set of 
beliefs and practices that facilitate these spiritual experiences; religion is one 
of the lenses through which spirituality can be accessed (A. Visser et al., 
2010). Religiosity is thus a measure of adherence to such beliefs and practices, 
which may or may not correlate with levels of spirituality (Chiu et al., 2004; 
Paloutzian & Park, 2005).  
Theories. Spirituality can be conceived as a dimension of existential 
wellbeing, alongside physical and mental domains (Edmondson, Park, Blank, 
Fenster, & Mills, 2008; H.-R. Lin & Bauer-Wu, 2003); however, much of the 
existing literature has suggested that an innate, stable, cognitive (insofar as it 
requires active awareness) resource (Dein, Cook, & Koenig, 2012; Puchalski, 
2012). Spirituality thus often comprises two facets: a sense of meaning, peace, 
and purpose in life; and the faith that “things will be okay”, or a sense of 
strength and comfort that is often correlated strongly with religion and 
religiosity (Meraviglia, 2006; Park, 2010; Peterman, Fitchett, Brady, 
Hernandez, & Cella, 2002).  
Oncology settings. In oncology settings, spirituality has also long been 
identified as essential to QOL (H.-R. Lin & Bauer-Wu, 2003). Spirituality 
allows patients to reframe their situation, draw meaning from their cancer 
journey and find peace, and thus better cope with the diagnosis regardless of 
the outcomes (Park, 2013; Puchalski, 2012; Raja Lexshimi et al., 2014). It is 
therefore no surprise that spirituality, comprising meaning and faith, has been 
linked not only to hopefulness, help-seeking behaviour, and treatment 
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adherence, but also to fewer symptoms of fatigue (Jun & Ko, 2012), emotional 
distress, and fears of death (H.-R. Lin & Bauer-Wu, 2003; Park, 2013; 
Puchalski, 2012). Calls for holistic cancer care have suggested that 
incorporating some aspect of spirituality or religion in addition to existing 
palliative support may better meet the needs of cancer patients across the 
cancer journey (Meraviglia, 2006; Peteet & Balboni, 2013; Vachon, 2008). 
A number of published reviews are available on the beneficial effects 
of spirituality on psychological wellbeing (including reducing the symptoms 
of depression and anxiety) in patients diagnosed with cancer (H.-R. Lin & 
Bauer-Wu, 2003; Thuné-Boyle, Stygall, Keshtgar, & Newman, 2006; A. 
Visser et al., 2010). A significant number of articles employing such 
logotherapeutic modalities have also suggested that psychological 
interventions that incorporate some form of spiritual care or aspects of 
spirituality (secular or not) are effective in facilitating cancer patients’ 
adjustment to the disease and their prognosis (Breitbart, 2002; Hsiao, Gau, 
Ingleton, Ryan, & Shih, 2011; Peteet & Balboni, 2013). Some, however, have 
also challenged the efficacy of spirituality and its associated therapies in 
enhancing psychological wellbeing, citing only cross-sectional work with non-
rigorous methodology (Stefanek, McDonald, & Hess, 2005; A. Visser et al., 
2010). Further, no clear definitive research has examined the course of 
spirituality across time. 
There has, however, been some work on spirituality in Asian cancer 
patients, although this has not yet been formally synthesised. Reviews up to 
2010 found three papers examining spirituality in this population, and a quick 
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search on PubMed in the last half a decade surfaced another three. Similar to 
patients in the (majority Christian-dominant) West (and even the Muslim-
domainant Middle East; Lazenby, Khatib, Al-Khair, & Neamat, 2013), 
spiritual cancer patients had better coping (Ahmad, Muhammad, & Abdullah, 
2011) and help-seeking (Au, Zauszniewski, & King, 2012), and fewer 
symptoms of fatigue (Jun & Ko, 2012), depression, and anxiety (H.-R. Lin & 
Bauer-Wu, 2003; Raja Lexshimi et al., 2014).  
There is also some evidence that there is poor cross-cultural validity of 
spirituality as defined by the West (C. H. Y. Chan et al., 2014): beneficial 
effects of spirituality have been found in Asian-Americans (K.-Y. Wen, Fang, 
& Ma, 2014) but not in those from where they emigrated (J. Lim & Yi, 2009). 
Some evidence has suggested that this has less to do with being Asian than 
with being migrant (Moadel & Harris, 2008). Collectively, these findings 
suggest that much still needs to be determined with respect to the role of 
spirituality in Asian cancer patients, although there is some compelling 
evidence suggesting that interventions incorporating such elements may 
improve the wellbeing of such patients regardless of religion. 
Limitations of Previous Studies 
The prevalence of depressive and anxious symptomatology are 
significant in patients diagnosed with cancer, and high levels of such 
symptoms that do not meet a clinical threshold may foreshadow more 
insidious clinical psychiatric sequelæ that may influence behaviours leading to 
mortality and survivorship. Because of the significant overlap in the somatic 
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symptoms of these sequelæ, the targets of interventions are focused on the 
non-somatic (predominantly cognitive) symptomatology.  
Asian cancer patients, however, are less likely to access such formal 
psychological and psychiatric services primarily due to cultural stigmas and 
notions of help seeking. When coupled with the rising cancer incidence rates 
in Asians, this results in significantly higher rates of depression and anxiety 
and subsyndromal symptoms amongst Asian cancer patients as compared to 
the Western populations.  
It is thus essential to support cancer outpatients even in time-deficient 
clinics that primarily on medical, and not psychological, care. Cancer patients’ 
emotional sequelæ are often moderated by innate traits, or positive 
psychosocial resources, such as hope, optimism, resilience, mindfulness, and 
spirituality. Higher levels of such positive psychosocial resources have been 
found to significantly reduce symptoms of depression and anxiety in patients 
diagnosed with cancer.  
Associations of psychosocial resources and depression and anxiety 
in Asian cancer patients. Research on the associations and influence of these 
resources influence in Asian cancer patients is, however, wanting. Few studies 
have specifically investigated the associations between these positive 
psychosocial resources on depression and anxiety, despite suggestions for 
improvements in these resources as key to cancer care globally. It is thus 
necessary to verify the relationships between these positive psychosocial 
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resources and non-somatic symptoms of depression and anxiety in a local 
Asian population.  
Influence of psychosocial resources on depression and anxiety in 
Asian cancer patients. Further, there is also a lack of understanding on the 
predictive and collective cross-sectional longitudinal influence of these 
intrapersonal resources on the emotional sequelæ of cancer patients. Past work 
both in the West and Asia has only looked at these resources individually (e.g., 
Hou et al., 2010), without considering their collective influence and the 
relative importance of these resources on depression and anxiety (i.e., which 
resources are found to be more important than the rest). Further, past work has 
also only examined latent constructs without specific investigations into its 
components or subscales (e.g., Yang et al., 2014): some of these psychosocial 
variables (hope, mindfulness, spirituality) are multifaceted, and may exert 
differential effects on levels of depression and anxiety. In addition, while past 
research has suggested that psychosocial resources, over and above social 
resources, may affect patients’ QOL (Helgeson, Snyder, & Seltman, 2004), 
none have examined these relationships over and above sociodemographic and 
medical variables, which may themselves influence symptoms of depression 
and anxiety (Mahendran, Lim, Tan, Kua, & Griva, 2015; Yang et al., 2013).  
Course of psychosocial resources in Asian cancer patients. In 
addition to the paucity of work done in Asian cancer patients, it is still unclear 
as to the course of these positive psychosocial resources longitudinally as 
much work has been cross-sectional or assumed the stability of such innate 
cognitive resources. While this may be true, the cancer diagnosis is a 
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traumatic one that may lead to post-traumatic growth, with consequent 
changes in these resources; no study has yet established the course of this, 
much less in an Asian context, although some have suggested that it fluctuates 
in tandem with psychological wellbeing (e.g., Hou et al., 2010).  
Course and prevalence of subsyndromal depression and anxiety in 
Asian cancer outpatients. Finally, information on the prevalence and course 
of subsyndromal anxiety and depression globally is sparse, with a majority of 
research being cross-sectional and in Western contexts (Jacobsen & Donovan, 
2011) and none using locally-validated cut-offs for subsyndromal 
classification. Even then, recent literature has not yet agreed on a general 
direction, with some suggesting decreases in symptoms across time (e.g., 
Oerlemans et al., 2014), while others suggest stability (e.g., Stafford et al., 
2015). Past studies on the local cancer population have identified the 
prevalence of clinically depressed and anxious inpatients (S. M. Tan et al., 
2014) and those with caseness of (or subsyndromal) depression and anxiety in 
outpatients’ first visit to the oncologist (H. A. Lim, Mahendran, Chua, et al., 
2014). The sample in both studies may have been predisposed to higher levels 
of depressive and anxious symptoms: Tan and colleagues (2014) interviewed 
inpatients, who presumably had life-threatening comorbidities or at the 
terminal stages of their illness; while Lim and colleagues (2014) rated 
outpatients on internationally recognised, but not locally specific, cut-offs at 
the first visit to the oncologist where there is generally a great deal of pre-
emptive or post-diagnostic anxiety. Further, both studies were cross-sectional, 
and did not examine the stability or course of such subsyndromal depression 
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and anxiety longitudinally. No studies on Asian cancer patients have yet 
examined the course of locally-validated subsyndromal levels of depression 
and anxiety in a cancer patients within the first 100 days of being diagnosed, 
which is touted as the key period for cancer patients (Johnson et al., 2012).  
Objectives and Hypotheses of the Present Study 
Given the limitations of previous studies, this thesis therefore sought to 
explore the relationships between positive psychosocial resources (such as 
hope, optimism, resilience, mindfulness, and spirituality) and the non-somatic 
depressive and anxious symptomatology in Asian patients diagnosed with 
cancer across their first year of diagnosis. As such, the objectives of the 
present exploratory study were therefore fourfold: 
1.! To determine the course of psychosocial resources 
controlling for sociodemographic and medical variables; 
2.! To determine the prevalence of subsyndromal depression 
and anxiety, and the course of caseness and depressive and 
anxious symptoms controlling for sociodemographic and 
medical variables; and  
3.! To investigate the cross-sectional associations between 
these psychosocial resources and symptoms of depression 
and anxiety at each time point; and 
4.! To investigate the collective cross-sectional and 
longitudinal influence of these resources and components 
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on these symptoms over and above sociodemographic and 
medical variables 
in a local Asian cancer outpatient sample across their first year of diagnosis. 
Because the present study was exploratory in nature, no a priori hypotheses 
were generated for the first, second, and fourth objectives. For the third 
objective, based on past literature, it was hypothesised that hope, optimism, 
resilience, mindfulness, and spirituality will independently correlate 
negatively with symptoms of depression and anxiety cross-sectionally at all 
time points. 
This rest of this thesis is broadly divided into three chapters. Chapter 2 
describes the methodology employed to address these research questions. 
Chapter 3 presents the findings of the study and Chapter 4 discusses these 
findings and situates them in the larger context of holistic psychosocial 




This chapter describes the methods employed in the present study to 
investigate the aforementioned research questions. It begins with a description 
of the larger cohort study from which the sampling frame is drawn, and 
explicates the data collection methods, the instruments used in the present 
study, the final subset of participants selected for the present study, as well as 
the plan for data analysis. 
Study Design and Ethics 
The present study is part of an on-going observational prospective 12-
month cohort study on the psychiatric sequelæ of newly-diagnosed ambulatory 
cancer patients and its associations with patients’ psychosocial resources and 
caregiver burden (the HOPE Study; Mahendran, Lim, & Tan, 2014). Ethics 
approval was granted by the National Healthcare Group Domain-specific 
Review Board (Reference: 2013/00294), and all patients provided informed 
written consent. Appendix A presents the ethics approvals for the HOPE 
Study and Appendix B presents the informed consent forms. The HOPE Study 
is funded by the National University of Singapore Start-Up Grant 
(NUHSRO/2012/068/SU/01).  
Inclusion/Exclusion Criteria 
To be included in the HOPE study, patients had to be (a) between 21 
and 64 years of age, (b) recently-diagnosed (within the last five months) with 
cancer (regardless of site and stage), and (c) of any gender, ethnicity, or 
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nationality. Patients were excluded if they (d) were unable to communicate in 
English, (e) were receiving inpatient treatment, or (f) had a recurrent cancer 
within the past two years.  
To improve the homogeneity of the sample for the present study, 
additional (ad hoc) criteria were imposed for the analyses presented in this 
thesis: patients were included only if they (g) identified as Asian, (h) had a 
first (i.e., not recurrent) cancer diagnosis, and (i) had been diagnosed within 
three months (approximately the first 100 days) at the point of recruitment. 
Procedures 
Between July 2013 and June 2014, newly diagnosed outpatients from 
the medical-, surgical-, and radiation-oncology units of a large cancer centre in 
Singapore were invited to participate in the HOPE Study by trained research 
assistants. Participants were asked to complete self-report questionnaires at the 
point of recruitment (baseline; T0) for completion in the clinic, and at three 
(T1), and six (T2) months post-baseline. Partway through baseline recruitment 
(after 48 patients), the FACIT-Sp (see Study Instruments, page 45) was added 
to the assessment protocol. 
All baseline questionnaires were completed on site during a regularly 
scheduled outpatient appointment. Follow-up questionnaires were completed 
at the participants’ convenience. If participants’ follow-up time-frame (one 
week before or after the scheduled assessment date) did not coincide with a 
visit to the cancer centre, research assistants mailed questionnaires to them 
with a self-return envelope and instructions to complete the self-reports within 
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the time frame. A token participation fee of SGD 20 was given following 
administration or receipt of postal questionnaires. To ascertain that posted 
follow-up questionnaires were completed at the appropriate time point, those 
that were not post-marked within two weeks of the scheduled assessment dates 
were discarded.  
Participants 
For the HOPE study, 1444 patients were screened, and of the 427 who 
were eligible, only 221 patients (response rate: 52%) consented. The main 
reason for non-participation at time of recruitment was disinterest in 
completing the set of questionnaires. Figure 1 details the recruitment process.  
Based on the additional inclusion and exclusion criteria, three 
participants identified as non-Asians (Caucasians), nine had a recurrent cancer 
diagnosis, and 19 were diagnosed between four and five months ago, bringing 
the sampling frame for the present study to 190 (86% of) baseline HOPE study 
participants. Because the present study sought to primarily investigate the 
influence of psychosocial resources on depression and anxiety, only 
participants with complete data at baseline were included in the present study. 
The final sample comprised 142 participants (n = 3 only completed the 
sociodemographic and medical self-reports; n = 45 were not able to complete 
some questionnaires as they were later additions [see Procedures, page 41]). 
Of the 142 final baseline participants for this study, 6% (n = 8) passed 
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only data from 94 participants were captured at T1 (response rate: 68%), and 
83 were captured at T2 (response rate: 62%); the rest were lost to follow-up. 
The number of complete cases across all time points was 74 (completers rate: 
55%). 
Participants were, on average, aged 48.75 ± 9.26 years of age, with one 
in two participants women (n = 95). While the ethnic distribution of the 
sample closely mirrored the general Singapore population’s ethnic profile 
(Department of Statistics, 2015b), only 63% (n = 89) of participants identified 
as Chinese (vs. 84% of the local cancer population; National Registry of 
Diseases Office, 2015). Slightly over three-quarters (77%; n = 109) were 
married and living with their spouses, and completed at least secondary 
education (76%; n = 108; similar to the local population; Teo, 2013).  
Housing arrangements of the present sample were also similar to the 
local general population, albeit with a larger proportion (49%; n = 69) living 
in 3–4 roomed public housing (vs. 33% of the local population; Department of 
Statistics, 2015b). Given that participants were recruited from a government-
funded national cancer centre, 87% (n = 91) of those who reported their 
household income were below the local median of SGD 8,000 (Department of 
Statistics, 2015a), with 30% reporting income below SGD 2,000, a threshold 
that is often used as the upper limit for financial assistance in Singapore 
(Singapore Ministry for Social and Family Development, 2014). Demography-




Participants were recruited, on average, 1.82 ± 0.81 months (range: 2–
12 weeks) after being diagnosed with their cancer. Almost all participants 
(98%; n = 139) were undergoing chemotherapy, with about three in 20 were 
receiving concurrent radiotherapy (13%; n = 13) or had undergone surgery at 
point of recruitment (15%; n = 21). The distribution of cancers types in the 
present sample also approximated that of the local incidence profile (National 
Registry of Diseases Office, 2015).  
The most common cancers for men were: gastrointestinal (39%; n = 
17), nasopharyngeal (23%; n = 11), haematological (19%; n = 9), and lung 
(19%; n = 9). For women, they were: breast (47%, n = 45), gynaecological 
(18%, n = 17), gastrointestinal (17%, n = 16), and haematological (12%, n = 
11). Slightly over a third (35%; n = 49) of participants were diagnosed with 
late-stage or metastatic cancers. The most common reported medical 
comorbidities were hyperlipidaemia (15%; n = 22), diabetes mellitus (12%; n 
= 17), and hypertension (11%; n = 15). Table 1 details the baseline 
demography and clinical variables of the present sample. 
Study Instruments 
Sociodemographic and medical parameters. Participants completed 
a basic sociodemographic and medical self-report at baseline. Appendix C 
presents this self-report. Participants’ treatment that they had undergone or 
were undergoing were drawn from their self-reports and classified, broadly 
and non-exclusively, into surgery, chemotherapy, and radiotherapy (National 
Cancer Institute, 2015c). Medical information on their comorbidities, cancer  
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Table 1:  
 
Baseline Sociodemographic and Medical Variables 
  
Variable  N = 142 
Age  48.75 ± 9.26 
Gender   
   Men  47 (33) 
   Women  95 (67) 
Ethnicity   
   Chinese  89 (63) 
   Non-Chinesea  53 (37) 
Education   
   No formal  12 (8) 
   Primary  22 (16) 
   Secondary  40 (28) 
   Tertiary  21 (15) 
   Quaternary  47 (33) 
Marital Status   
   Married and Living Together  109 (77) 
   Separated/Divorced/Widowed/Never Married    33 (23) 
Living Arrangement   
   Living with Others  151 (98) 
   Living Alone  3 (2) 
Housing   
   1–2 Room Public Housing  6 (4) 
   3–4 Room Public Housing  69 (49) 
   5 Room Public Housing or Private Housing  67 (47) 
Total Household Income   
   < $2000  31 (22) 
   $2000–8000   60 (42) 
   > $8000  14 (10) 





Time from Diagnosis (months)  1.83 ± 0.81 
Treatment Received/Receivingb   
   Chemotherapy  139 (98) 
   Radiotherapy  19 (13) 
   Surgery  21 (15) 
Cancer Type   
   Breast  45 (32) 
   Gastrointestinal  33 (23) 
   Haematological  20 (14) 
   Gynaecological  17 (12) 
   Nasopharyngeal  14 (10) 
   Lung  12 (9) 
   Renal   1 (1) 
Cancer Stage   
   Early Stage  93 (65) 
   Late/Metastatic Stage  49 (35) 
Comorbidities   
   Hyperlipidaemia  22 (15) 
   Diabetes Mellitus  17 (12) 
   Hypertension  15 (11) 
   Cardiovascular Disease  3 (2) 
Notes. Data are presented as either M ± SD or n (%). aNon-Chinese comprise of 
ethnic minority groups, namely, Malay, Indian, and Eurasians. bParticipants may have 
received or may be receiving more than one type of therapy; as such, the figures 




site, and cancer staging, however, were drawn from their medical records. 
Because cancer staging (based either on the TNM or Overall Stage 
classifications) is specific and cannot be generalised across the various cancer 
types (National Cancer Institute, 2015d), cancer diagnoses were broadly 
categorised into early (Stages 0–II) and advanced stages (Stages III and above, 
as well as any primary cancer that had metastasised). 
Participants also completed the following self-report measures at all 
time points. Appendix D presents the relevant sections of the questionnaire 
used in the present study. 
Hospital Anxiety and Depression Scale. Depressive and anxious 
symptomatology were measured with the Hospital Anxiety and Depression 
Scale Version 2 (HADS; Zigmond & Snaith, 1983), a widely-used and 
validated instrument in medical settings (Bjelland, Dahl, Haug, & 
Neckelmann, 2002; Snaith, 2003). The HADS was selected for use in this 
study above other measures of these symptoms because it excludes somatic 
symptomatology that often overlap with the side effects of symptoms 
associated with cancer progression or treatment, and has been previously used 
to this effect (K. F. Y. Lam, Lim, Tan, & Mahendran, 2015). Coupled with its 
brevity, the HADS is considered one of the best tools for measuring 
depressive and anxious symptomatology in cancer patients (Pasquini & Biondi, 
2007; Stark et al., 2002). 
The HADS consists of 14 items rated on a four-point Likert-type scale 
(ranging from 0 = ‘Yes, definitely’ to 3 = ‘No, not at all’) that load on two 
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subscales: depression (HADS-D; e.g., “I feel as though I have slowed down”) 
and anxiety (HADS-A; e.g., “Worrying thoughts go through my mind”). As 
suggested, an aggregate of scores for each subscale (ranging 0–21) was 
calculated, with higher scores indicating higher levels of anxiety or depression 
(Zigmond & Snaith, 1983).  
The HADS is frequently employed as a screening tool in oncology 
clinics worldwide (Mitchell, Meader, & Symonds, 2010), and has previously 
been validated for use in a local population sample of newly-diagnosed cancer 
outpatients (H. A. Lim, Mahendran, Chua, et al., 2014) and inpatients (S. M. 
Tan et al., 2014). Both HADS subscales demonstrated good reliability in the 
present sample at all assessments (αs = .81–.88 for depression; αs = .83–.91 
for anxiety). Locally validated interview-based thresholds for Singapore’s 
cancer population (HADS-D  7 and HADS-A  5; K. R. Beck et al., 2014), 
in line with internationally recommended guidelines (Vodermaier & Millman, 
2011), were used to identify participants with subsyndromal levels (‘caseness’) 
of depression and anxiety. As such, data from the HADS subscales were 
analysed as both categorical (based on subsyndromal cut-offs) and continuous. 
Adult Hope Scale. Hope was measured with the Adult Hope Scale 
(AHS; Snyder et al., 1991), a 12-item self-report instrument rated on an eight-
point Likert-type scale (ranging from 1 = ‘Definitely False’ to 3 = ‘Definitely 
True’). Only eight of the AHS items measure patients’ level of dispositional 
hope, and load onto two subscales: agency (e.g., “I energetically pursue my 
goals”) and pathway (e.g., “There are lots of ways around any problem”). As 
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suggested, an aggregate score from each subscale was calculated and 
combined to form a global score (ranging 8–64), where higher scores reflect a 
greater sense of hope (Snyder et al., 1991).  
The AHS is considered one of the best measures of hope (Steed, 2002). 
It has been validated and used in both medical and non-medical settings 
(Snyder, 2002), and has been previously used with Asian cancer patients (e.g., 
Hou et al., 2010). In the present sample, the AHS demonstrated good 
reliability at all assessments (αs = .87–.93 for hope; αs = .76–.86 for agency; 
αs = .81–.86 for pathway). 
Revised Life Orientation Test. Optimism was measured with the 
Revised Life Orientation Test (LOT-R; Scheier et al., 1994), a 10-item self-
report instrument on a five-point Likert-type scale (ranging from 0 = ‘Strongly 
Disagree’ to 4 = ‘Strongly Agree’). Only six of LOT-R items measure an 
individual’s dispositional positive expectations of future outcomes; half of 
these are worded positively (e.g., “In uncertain times, I usually expect the 
best”) and the other half are worded negatively (e.g., “If something can go 
wrong for me, it will”). As suggested, an aggregated total score (ranging 0–24) 
was calculated, with higher scores reflecting higher levels of optimism 
(Scheier et al., 1994).  
The LOT-R is considered one of the best measures of optimism (Burke, 
Joyner, Czech, & Wilson, 2000; Steed, 2002). It has been validated and used 
in both medical and non-medical settings (Andersson, 1996), and has been 
previously used with Asian cancer patients (e.g., Hou et al., 2010). In the 
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present sample, the LOT-R demonstrated acceptable reliability at all 
assessments (αs = .51–.62), similar to that in other samples (Andersson, 1996). 
Resilience Scale. Resilience was measured with the 14-item Resilience 
Scale (RS-14; Wagnild & Young, 1993; Wagnild, 2011), a self-report 
instrument on a seven-point Likert-type scale (ranging from 1 = ‘Strongly 
Disagree’ to 7 = ‘Strongly Agree’) that measures the degree of an individual’s 
dispositional psychological resilience (e.g., “I usually manage one way or 
another”). As suggested, an aggregated total score (ranging 14–98) was 
calculated, with higher scores reflecting greater resilience (Wagnild, 2011).  
The RS-14 is considered one of the best measures of resilience 
(Windle, Bennett, & Noyes, 2011). It has been validated and used in both 
medical and non-medical settings (Eicher et al., 2015; Stewart & Yuen, 2011), 
and has been previously used with Asian cancer patients (e.g., Tian & Hong, 
2014). In the present sample, the RS-14 demonstrated excellent reliability at 
all assessments (αs = .92–.93), similar to that in other samples (Eicher et al., 
2015). 
Five-Facet Mindfulness Questionnaire. Mindfulness was measured 
with the Short Form of the Five-Facet Mindfulness Questionnaire (FFMQ-SF; 
Baer et al., 2006; Bohlmeijer, ten Klooster, Fledderus, Veehof, & Baer, 2011), 
a 24-item self-report instrument on a five-point Likert-type scale (ranging 
from 1 = ‘Never or very rarely true’ to 5 = ‘Very often or always true’). The 
FFMQ-SF measures an individual’s dispositional mindfulness on five facets: 
(a) describing (e.g., “I am good at finding the words to describe my feelings”); 
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(b) observing (e.g., “I pay attention to physical experiences, such as the wind in 
my hair or the sun on my face”); (c) non-reacting (e.g., “When I have 
distressing thoughts or images, I just notice them and let them go”); (d) non-
judging (e.g., “I tell myself that I shouldn’t be thinking the way I’m thinking”); 
and (e) acting with awareness (e.g., “It seems I am ‘running on automatic’ 
without much awareness of what I’m doing”). As suggested, an aggregate score 
from each subscale was calculated and combined to form a global score 
(ranging 24–120), with higher scores reflecting greater levels of mindfulness 
(Bohlmeijer et al., 2011). 
The FFMQ-SF is considered one of the best measures of mindfulness 
(Bergomi, Tschacher, & Kupper, 2013). It has been validated and used in both 
medical and non-medical settings (Christopher et al., 2012), and while it has 
been previously used with cancer patients (Christopher et al., 2012), to the 
best of our knowledge, it has never been used in an Asian oncology population. 
In the present sample, the FFMQ-SF demonstrated good reliability at all 
assessments (αs = .69–.76 for mindfulness; αs = .70–.76 for describing; αs 
= .76–78 for observing; αs = .71–.73 for non-reacting; αs = .71–.76 for non-
judging; αs = .78–.87 for acting with awareness). 
Functional Assessment of Chronic Illness Therapy Spirituality 
Subscale. Spirituality was measured with the 12-item spirituality subscale of 
the Functional Assessment of Chronic Illness Therapy (FACIT-Sp-12; Bredle, 
Salsman, Debb, Arnold, & Cella, 2011; Peterman et al., 2002), a self-report 
instrument on a five-point Likert-type scale (ranging from 0 = ‘Not at all’ to 4 
= ‘Very much’). While there is presently an on-going debate regarding the 
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factor structure of the FACIT-Sp-12 (Canada, Murphy, Fitchett, Peterman, & 
Schover, 2008; Murphy et al., 2010), evidence still suggests that, for cancer 
patients, the items on the FACIT-Sp-12 load onto two subscales (Peterman et 
al., 2014): meaning/peace (e.g., “I feel a sense of purpose in my life”), and 
faith (e.g., “I find comfort in my faith or spiritual beliefs”). As suggested, an 
aggregate score from each subscale was calculated and combined to form a 
global score (ranging 0–48), with higher scores reflecting greater levels of 
spirituality (Peterman et al., 2002). 
The FACIT-Sp-12 is considered one of the best measures of 
spirituality as it transcends the archaic and non-inclusive Judeo-Christian 
definitions of spirituality that are often encumbered by religiosity (National 
Institute on Aging Working Group, 1999). It has been validated and used in 
both cancer and non-cancer settings (A. Visser et al., 2010), and has been 
previously used with Asian cancer patients (e.g., Noguchi et al., 2004). In the 
present sample, the FACIT-Sp-12 demonstrated good reliability at all 
assessments (αs = .87–.90 for spirituality; αs = .83–.94 for meaning/peace; αs 
= .88–.92 for faith). 
Data Analysis 
Data were also deemed normal based on Kolmogorov-Smirnov tests 
(ps > .05) and Q–Q plots; data were thus analysed with parametric tests in 
SPSS 22 (Chicago, IL) with alpha set at .05. Bonferroni corrections were 
employed for the relevant uncorrected analyses to reduce family-wise Type I 
errors. Regression models did not violate standard rules of thumbs for 
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multicollinearity (i.e., tolerance was above .10 and variance inflation factor 
[VIF] was less than 10; Field, 2009). 
Missing data. Data were free from acquiescence bias (Rughinis & 
Toader, 2010). Missing data were determined to be randomly distributed 
(ps > .05) based on Little’s Missing Completely at Random (MCAR) tests 
(Little, 1988). As such, aggregate scores (as described above in the section on 
Study Instruments, page 45) were calculated if at least half the items on the 
(sub)scale was completed.  
Data lost to follow-up. As suggested elsewhere (Kenward & 
Molenberghs, 2009), the last observation carried forward data approach (in 
which data from the last completed time-point would be imputed into 
subsequent missing time-points [at follow-ups]; Mallinckrodt, Clark, & David, 
2001) was not employed in the present analyses because of its unsubstantiated 
assumptions, especially in light of recent research on emotional distress in 
cancer patients (Bidstrup et al., 2015; Dunn et al., 2011; W. W. T. Lam et al., 
2013). As such, two-way multivariate analyses of covariance (MANCOVAs) 
using Wilk’s Lambda with post-hoc analyses were employed to determine 
baseline differences in baseline depression, anxiety, and psychosocial 
resources between completers and non-completers (i.e., participants who were 
captured at versus those lost to follow-up; see Participants, page 42) 
controlling for baseline sociodemographic and medical variables. Chi-square 
analyses or Fisher’s exact tests were also employed to ascertain if there were 
any differences in subsyndromal (caseness of) depression and anxiety (based 
on locally-validated cut-offs for the local cancer population; see Study 
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Instruments, page 45), as well as differences in demography between 
completers and non-completers. 
Univariate analyses. Means and standard deviations of the variables 
of interest across all time points were calculated and reported.  
Bivariate analyses. Pearson’s correlation coefficients were calculated 
to investigate the bivariate relationships between positive psychosocial 
resources and depression and anxiety cross-sectionally at all three time points.  
Multivariate analyses. Given the heterogeneous sample and past work 
on the HOPE Study suggesting the multifarious associations between 
demographic variables with depression and anxiety at various time points 
(Mahendran, Lim, Tan, Kua, et al., 2015), it was decided that the present 
analyses would control for all sociodemographic and medical variables 
presented in Table 1 (page 46) regardless of their significant associations with 
either the psychosocial resources or depression and anxiety. MANCOVAs 
were used instead of multiple analyses of covariance (ANCOVAs) for the 
analyses to reduce potential family-wise Type I errors, and because these 
variables of interest were correlated. 
Course of psychosocial resources over time. Two sets of repeated-
measures MANCOVAs using Wilk’s Lambda with post-hoc analyses were 
employed to determine the course of psychosocial resources: (a) across the 
three assessments (baseline [T0], 3-month follow-up [T1], and 6-month 
follow-up [T2]); and (b) across two pairs of the assessments (i.e., baseline and 
3-month follow-up [T0–T1] and baseline and 6-month follow-up [T0–T2]) as 
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confirmatory analyses since the earlier MANCOVA only accounted for 
completers (i.e., participants who had completed all three assessments).  
Course of symptoms of depression and anxiety over time. Two types 
of analyses determined the course of depression and anxiety across time. The 
first replicated the analyses for psychosocial resources using continuous 
HADS subscale scores of symptoms of depression and anxiety, i.e. two sets of 
repeated-measures MANCOVAs using Wilk’s Lambda with post-hoc analyses: 
(a) across the three assessments (T0, T1, and T2); and (b) across two pairs of 
the assessments (i.e., T0–T1 and T0–T2) as confirmatory analyses. The 
second used categorical data, as determined by locally validated cut-offs for 
the local cancer population (see Study Instruments, page 45), in McNemar’s 
tests with Bonferroni corrections to determine the course of subsyndromal (or 
caseness of) depression and anxiety across (three pairs of) the time points (i.e., 
T0–T1, T1–T2, T0–T2). 
Investigating the influence of psychosocial resources on depression 
and anxiety. Step-wise multivariate hierarchical linear regression models were 
constructed to determine the amount of variance in depression and anxiety (i.e., 
dependent variables) accounted for by the psychosocial resources (i.e. 
independent variables) over and above baseline sociodemographic and 
medical variables (i.e. control variables). For cross-sectional analyses, two 
types of models were tested: Model 1 was when depression or anxiety was 
regressed on only the overarching/latent variables (total scores, e.g. hope); 
Model 2 was when depression or anxiety was regressed on all psychosocial 
constructs (subscales, e.g., agency and pathways for hope). For cross-sectional 
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analyses each of these models (Models 1 and 2), depression and anxiety were 
regressed in two steps: Step 1 included all control variables, and Step 2 
included all independent variables. For longitudinal analyses, these two types 
of regression models (Models 1 and 2) were also employed, but Step 1 in these 




This chapter presents the findings of the present study. It first presents 
the differences between responders and non-responders, before examining the 
course of the variables of interest across time. It then examines the cross-
sectional and longitudinal relationships between these positive psychosocial 
resources and depression and anxiety. 
Differences between Completers and Non-completers 
Chi-square analyses with Fisher’s exact tests where appropriate 
revealed that there were no significant differences in the demography between 
completers and non-completers on all sociodemographic and medical 
variables (ps > .05). These results suggested that there was no systematic 
difference in participants whose data were lost to follow-up (non-completers). 
A two-way multivariate analysis of covariance (MANCOVA) 
controlling for all baseline sociodemographic and medical covariates 
suggested that there were no significant differences in the baseline levels of 
positive psychosocial resources, depression, and anxiety and between 
completers and non-completers (Λ = .93, F[7,105] = 1.22, p = .30). These 
results suggested that scores on psychosocial variables and depression and 
anxiety were comparable between completers and non-completers. Table 2 
presents the estimated means in the scores on all variables of interest between 





























































































































































































































































































































































































































































































































































































































Chi-square analyses with Fisher’s exact tests also revealed that there 
were no significant differences in the prevalence of baseline subsyndromal 
depression and anxiety between completers and non-completers (ps ≥ .05). 
These results suggested that the percentage of participants with caseness of 
depression and anxiety based on locally validated cut-offs for the cancer 
population were similar across both groups. Collectively, these analyses 
further reinforced that data was missing completely at random and subsequent 
analyses with missing data were not significantly biased and could be 
generalised. 
Course of Psychosocial Resources 
Repeated-measures MANCOVA controlling for all baseline 
sociodemographic and medical variables revealed that there were no 
significant differences in levels of psychosocial resources across the three 
assessments (i.e.; baseline [T0], 3-month follow-up [T1], and 6-month follow-
up [T2]; Λ = .91, F[10,37] = 0.36, p = .96). Confirmatory sets of similar 
repeated-measures Bonferroni-corrected MANCOVAs (accounting for non-
completers) across two pairs of the time-points—baseline and 3-month follow-
up (T0–T1; Λ = .97, F[5,60] = 0.37, p > .99) and baseline and 6-month 
follow-up (T0–T2; Λ = .95, F[5,49] = 0.52, p > .99)—also revealed that there 
were no significant differences across time. These findings collectively 
suggested that psychosocial resources were stable across time. As such, and as 
done elsewhere (Z. M. Tan et al., 2015), subsequent analyses only used 
baseline psychosocial resources to ascertain the longitudinal predictive value 
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on depression and anxiety. Table 3 presents the descriptive statistics for the 
psychosocial resources. 
Course of Depression and Anxiety 
Two sets of analyses determined the course of depression and anxiety 
across time. First, repeated-measures MANCOVA controlling for all baseline 
sociodemographic and medical variables revealed that there were no 
significant differences in levels of symptoms of depression and anxiety across 
the three assessments (i.e.; T0, T1, and T2; Λ = .87, F[4,40] = 1.54, p = .21). 
Confirmatory sets of similar repeated-measures Bonferroni-corrected 
MANCOVAs (accounting for non-completers) across two pairs of the time-
points—T0–T1 (Λ = .95, F[2,60] = 1.62, p = .42) and T0–T2 (Λ = .88, F[2,48] 
= 3.33, p = .08)—also revealed that there were no significant differences 
across time. These findings collectively suggested that symptoms of 
depression and anxiety were stable across time.  
Table 3 presents the descriptive statistics for depression and anxiety 
symptoms over time. The mean levels of depressive symptomatology across 
time ranged from 5.19–5.92 (SDs = 4.07–5.28), below locally validated 
caseness (subsyndromal) cut-offs of 7. The mean levels of anxious 
symptomatology across time ranged from 6.81–7.18 (SDs = 4.05–5.14), above 
locally validated caseness (subsyndromal) cut-offs of 5. 
Prevalence of subsyndromal depression and anxiety over time. 
Second, Bonferroni-corrected McNemar’s tests revealed that the prevalence of  
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Table 3:  










Hope (AHS)  47.26 ± 11.10 45.63 ± 11.20 45.35 ± 11.76 
Optimism (LOT-R)  15.53 ± 3.93 14.60 ± 3.45 14.64 ± 3.70 
Resilience (RS-14)  75.87 ± 14.64 73.60 ± 13.59 75.06 ± 12.52 
Mindfulness (FFMQ-SF)  78.41 ± 9.88 77.50 ± 9.33 78.22 ± 10.11 
Spirituality (FACIT-Sp-12)  36.31 ± 8.56 35.72 ± 8.43 35.22 ± 8.95 
Depression (HADS-D)  5.19 ± 4.07 5.69 ± 4.33 5.92 ± 5.28 
Anxiety (HADS-A)  6.81 ± 4.05 7.03 ± 4.25 7.18 ± 5.14 
Notes. Data are presented M ± SD based on all available cases per study instrument 
per assessment. Details on study instruments can be found on page 45. 
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subsyndromal (or caseness of) depression and anxiety based on locally 
validated cut-offs remained unchanged across time (all McNemar’s ps > .05). 
These results suggested that the prevalence of participants with subsyndromal 
depression and anxiety remained stable across time. 
As such, 32–39% of participants were found to have subsyndromal 
depression, and 67–72% were found to have subsyndromal anxiety over the 
three assessments (baseline, and 3- and 6-month follow-up). Of the complete 
cases with available HADS data (n = 71), 17% had persistent subsyndromal 
depression (n = 12) and almost half were found to have persistent 
subsyndromal anxiety (n = 35; scores consistently in the subsyndromal range). 
Figure 2 details the proportion of participants scoring in the locally validated 
subsyndromal ranges of depression and anxiety across time. 
Cross-sectional Associations between Variables of Interest 
Positive psychosocial resources. Correlational analyses suggested that 
there were significant negative correlations between the five positive 
psychosocial resources and depression and anxiety (all ps < .05). These results 
suggest that higher levels of hope (|rs[78–142]| = .28–.55), optimism (|rs[78–
142]| = .35–.49), resilience (|rs[78–142]| = .32–.57), mindfulness (|rs[78–142]| 
= .37–.48), and spirituality (|rs[78–142]| = .41–.64) were all associated with 
fewer non-somatic symptoms of depression and anxiety. Table 4 presents the 
cross-sectional correlations between these variables of interest. 
Positive psychosocial components. Further correlation analyses, 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































associated with depression and anxiety, specifically for mindfulness. The 
aspects of Observing and Non-judging did not have consistent cross-sectional 
negative correlations with depression and anxiety. These results suggest that 
the Observing aspect of mindfulness was only related to non-somatic 
symptoms of depression at T1, while the Non-judging aspect of mindfulness 
was only related to non-somatic symptoms of anxiety at T0. Table 4 also 
presents the cross-sectional correlations between these components of interest. 
Influence of Baseline Psychosocial Resources on Depression 
Cross-sectional analyses at baseline. Regression analyses involving a 
multivariate hierarchical model that accounted for all baseline 
sociodemographic and medical variables (Model 1) revealed that psychosocial 
resources accounted for an additional 34% of variance in baseline depressive 
symptoms (R2 = .53; F[34,107] = 3.55, p < .001). Amongst all the baseline 
psychosocial resources, hope (β = −.30, t[141] = −2.42, p = .017) and 
resilience (β = −.27, t[141] = −2.26, p = .026) remained significant in their 
influence of depressive symptomatology.  
Further regression analyses expanding the subscales of the 
psychosocial resources, where applicable, revealed that psychosocial resources 
accounted for an additional 43% of variance in baseline depressive symptoms 
(R2 = .62; F[40,101] = 4.15, p < .001) over and above all baseline 
sociodemographic and medical variables (Model 2). Amongst the baseline 
psychosocial resources, pathways to hope (from AHS; β = −.33, t[141] = 
−2.87, p = .005), meaning/peace (from FACIT-Sp-12; β = −.41, t[141] = −3.47, 
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p = .001), and faith (from FACIT-Sp-12; β = .24, t[141] = 2.83, p = .006) 
remained significant in their influence of depressive symptomatology.  
Table 5 presents the values the final step in the regression for Models 1 
and 2. Collectively, these results suggested that higher levels of hope, 
specifically pathways to hope, were related to fewer symptoms of depression. 
While having found more meaning/peace were related to fewer symptoms of 
depression; higher levels of faith, however, were related to more symptoms of 
depression. 
Longitudinal analyses for T1 (three month follow-up). Regression 
analyses involving a multivariate hierarchical model that accounted for all 
baseline sociodemographic and medical variables and baseline depression 
(Model 1) revealed that psychosocial resources accounted for an additional 6% 
of variance in scores of symptoms of depression at the 3-month follow-up (T1; 
R2 = .65; F[34,55] = 2.96, p < .001). Amongst all the baseline psychosocial 
resources, only spirituality (β = −.42, t[89] = −2.93, p = .005) was predictive 
of depressive symptomatology at T1 over and above baseline depression.  
Further regression analyses expanding the subscales of the 
psychosocial resources, where applicable, revealed that psychosocial resources 
accounted for an additional 10% of variance in depressive symptomatology 
scores (R2 = .68; F[40,49] = 2.66, p = .001) over and above all baseline 
sociodemographic and medical variables and baseline depression scores 
(Model 2). Amongst the baseline psychosocial resources, only meaning/peace 
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Table 5:  
Final Step for Regression of Baseline Depressive Symptoms on Baseline 
Psychosocial Resources 
Baseline Variable 
 Model 1a (R2 = .53)***  Model 2a (R2 = .62)*** 
 B SE(B) β  B SE(B) β 
Hope (AHS)  −0.11 .05   −.30*     
   Agency         0.17 .08 .02 
   Pathway       −0.22 .08  −.33* 
Optimism (LOT-R)  −0.06 .10 −.06  −0.07 .09 −.07    
Resilience (RS-14)  −0.07 .03  −.28*  −0.05 .03 −.18 
Mindfulness (FFMQ-SF)  −0.06 .04 −.14     
   Non-reactivity         0.04 .10  .04 
   Observing         0.07 .09 .07 
   Acting with Awareness         0.04 .10 .04 
   Describing       −0.09 .09 −.09 
   Non-judging       −0.11 .10 −.11 
Spirituality (FACIT-Sp-12)  −0.03 .05 −.07     
   Meaning/Peace       −0.28 .08 −.41*** 
   Faith         0.23 .08 .24** 
Notes. aControlling for all baseline sociodemographic and medical variables. Model 1 = Uses 
only latent total scores from study instruments. Model 2 = Uses subscale scores from study 
instruments where available and latent total scores where unavailable, e.g., Hope total scores 
are replaced by Agency and Pathway subscales. *p < .05, **p < .01, ***p < .001 
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(from FACIT-Sp-12; β = −.44, t[89] = −2.21, p = .032) was predictive of 
depressive symptomatology at T1 over and above baseline depression.  
Table 6 presents the values the final step in the regression for Models 1 
and 2 for T1. Collectively, these results suggested that baseline spirituality 
was predictive of depression at T1. Specifically, having found more 
meaning/peace at baseline would predict fewer symptoms of depression three 
months later.  
Longitudinal analyses for T2 (six-month follow-up). Regression 
analyses involving a multivariate hierarchical model that accounted for all 
baseline sociodemographic and medical variables and baseline depression 
(Model 1) revealed that psychosocial resources accounted for an additional 10% 
of variance in scores of symptoms of depression at the 6-month follow-up (T2; 
R2 = .78; F[34,43] = 1.98, p = .017). Amongst all the baseline psychosocial 
resources, only spirituality (β = −.42, t[77] = −2.23, p = .031) was predictive 
of depressive symptomatology at T2 over and above baseline depression.  
Further regression analyses expanding the subscales of the 
psychosocial resources, where appliacable, revealed that psychosocial 
resources accounted for an additional 10% of variance in depressive 
symptomatology scores (R2 = .80; F[40,37] = 1.66, p = .061) over and above 
all baseline sociodemographic and medical variables and baseline depression 
scores (Model 2). Amongst the baseline psychosocial resources, only faith 
(from FACIT-Sp-12; β = −.36, t[77] = −2.11, p = .041) was predictive of 
depressive symptomatology at T2 over and above baseline depression.  
  
Table 6:  
Final Step for Regression of Depressive Symptoms across Time on Baseline Psychosocial Resources 
Baseline Variable 
 3-month Follow-up (T1)  6-month Follow-up (T2) 
f Model 1a (R2 = .65)***  Model 2a (R2 = .68)***  Model 1a (R2 = .78)*  Model 2a (R2 = .80) 
 B SE(B) β  B SE(B) β  B SE(B) β  B SE(B) β 
Hope (AHS)    0.02 .07   .06        0.07 .10   .14     
   Agency       −0.04 .12 −.05        0.10 .20 .22 
   Pathway         0.04 .13  .06        0.13 .19  .15 
Optimism (LOT-R)    0.07 .15 .06    0.15 .16 .13    0.14 .22 .10    0.07 .24 .03 
Resilience (RS-14)    0.02 .05  .06    0.02 .05 .06  −0.12 .08 −.35  −0.16 .09 −.46 
Mindfulness (FFMQ-SF)  −0.01 .07 −.02        0.02 .09 .03     
   Non-reactivity       −0.14 .17  −.13      −0.28 .27  −.22 
   Observing       −0.16 .14 −.14        0.03 .20 .02 
   Acting with Awareness       −0.06 .17 −.05      −0.31 .30 −.23 
   Describing         0.31 .16 .25        0.24 .25 .18 
   Non-judging       −0.11 .16 −.10        0.10 .26 .08 
Spirituality (FACIT-Sp-12)  −0.21 .07 −.42**      −0.24 .11 −.41*     
   Meaning/Peace       −0.33 .15 −.44*        0.03 .23 .03 
   Faith       −0.13 .13 −.13      −0.43 .20 −.36* 
Notes. aControlling for all baseline sociodemographic and medical variables and depression. Model 1 = Uses only latent total scores from study instruments. Model 
2 = Uses subscale scores from study instruments where available and latent total scores where unavailable, e.g., Hope replaced by Agency and Pathway. *p < .05, 





Table 6 presents the values the final step in the regression for Models 1 
and 2 for T2. Collectively, these results suggested that baseline spirituality 
was predictive of depression at T2. Specifically, having more faith at baseline 
would predict fewer symptoms of depression six months later.  
Table 7 presents a summary of the results on the influence of baseline 
psychosocial resources on non-somatic depressive symptomatology across 
time. 
Influence of Baseline Psychosocial Resources on Anxiety 
Cross-sectional analyses at baseline. Regression analyses involving a 
multivariate hierarchical model that accounted for all baseline 
sociodemographic and medical variables (Model 1) revealed that psychosocial 
resources accounted for an additional 25% of variance in baseline anxious 
symptoms (R2 = .53; F[34,107] = 3.51, p < .001). Amongst all the baseline 
psychosocial resources, only mindfulness (β = −.27, t[141] = −2.83, p = .006) 
remained significant in their influence of anxious symptomatology.  
Further regression analyses expanding the subscales of the 
psychosocial resources, where applicable, revealed that psychosocial resources 
accounted for an additional 36% of variance in baseline anxious symptoms (R2 
= .63; F[40,101] = 4.35, p < .001) over and above all baseline 
sociodemographic and medical variables (Model 2). Amongst the baseline 
psychosocial resources, the non-judging aspect of mindfulness (from FFMQ-

























































































































































































































































































































































































































































































































































































12; β = −.36, t[141] = −3.10, p = .002) remained significant in their influence 
of anxious symptomatology. 
Table 8 presents the values the final step in the regression for Models 1 
and 2. Collectively, these results suggested that higher levels of mindfulness, 
specifically being less judgemental, were related to fewer symptoms of 
anxiety. Finding more meaning/peace was also related to fewer symptoms of 
anxiety. 
Longitudinal analyses for T1 (three-month follow-up). Regression 
analyses involving a multivariate hierarchical model that accounted for all 
baseline sociodemographic and medical variables and baseline anxiety (Model 
1) revealed that baseline psychosocial resources did not significantly account 
for any additional variance in scores of symptoms of anxiety at the 3-month 
follow-up (T1; R2 = .70; F[34,55] = 1.53, p = .08).  
Further regression analyses expanding the subscales of the 
psychosocial resources, where applicable, revealed that baseline psychosocial 
resources accounted for an additional 18% of variance in anxious 
symptomatology scores (R2 = .78; F[40,49] = 1.94, p = .014) over and above 
all baseline sociodemographic and medical variables and baseline anxiety 
scores (Model 2). Amongst the baseline psychosocial resources, the describing 
(from FFMQ-SF; β = .30, t[89] = 2.11, p = .04) and non-judging aspects of 
mindfulness (from FFMQ-SF; β = −.43, t[89] = −2.43, p = .019), as well as 
meaning/peace (from FACIT-Sp-12; β = −.64, t[89] = −3.14, p = .003) were 
predictive of anxious symptomatology at T1 over and above baseline anxiety. 
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Table 8:  
Final Step for Regression of Baseline Anxious Symptoms on Baseline 
Psychosocial Resources 
Baseline Variable 
 Model 1a (R2 = .73)**  Model 2a (R2 = .80)*** 
 B SE(B) β  B SE(B) β 
Hope (AHS)  −0.06 .05   −.16     
   Agency         0.38 .08 .06 
   Pathway       −0.14 .07  −.21 
Optimism (LOT-R)  −0.10 .10 −.10  −0.13 .09 −.13    
Resilience (RS-14)  −0.02 .03  −.07  −0.01 .03 −.01 
Mindfulness (FFMQ-SF)  −0.11 .04 −.27**     
   Non-reactivity       −0.15 .10 −.15 
   Observing         0.18 .09 .17 
   Acting with Awareness       −0.09 .10 −.08 
   Describing       −0.11 .09 −.10 
   Non-judging       −0.20 .10 −.21* 
Spirituality (FACIT-Sp-12)  −0.09 .05 −.19     
   Meaning/Peace       −0.25 .08 −.36** 
   Faith         0.10 .08 .10 
Notes. aControlling for all baseline sociodemographic and medical variables. Model 1 = Uses 
only latent total scores from study instruments. Model 2 = Uses subscale scores from study 
instruments where available and latent total scores where unavailable, e.g., Hope total scores 
are replaced by Agency and Pathway subscales. *p < .05, **p < .01, ***p < .001 
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Table 9 presents the values the final step in the regression for Models 1 
and 2 for T1. Collectively, these results suggested that being more adept at 
describing at baseline was predictive of higher levels of anxiety at T1, but 
being less judgemental and finding more meaning/peace at baseline would 
predict fewer symptoms of depression three months later. 
Longitudinal analyses for T2 (six-month follow-up). Regression 
analyses involving a multivariate hierarchical model that accounted for all 
baseline sociodemographic and medical variables and baseline anxiety (Model 
1) revealed that baseline psychosocial resources did not significantly account 
for additional variance in scores of symptoms of anxiety at the 6-month 
follow-up (T2; R2 = .72; F[34,43] = 1.39, p = .15).  
Further regression analyses expanding the subscales of the 
psychosocial resources, where applicable, confirmed these findings. Baseline 
psychosocial resources did not significantly account for additional variance in 
anxious symptomatology scores (R2 = .76; F[40,37] = 1.30, p = .22) over and 
above all baseline sociodemographic and medical variables and baseline 
anxiety scores (Model 2).  
Table 9 presents the values the final step in the regression for Models 1 
and 2 for T2. Collectively, these results suggested that baseline psychosocial 
resources did not significantly predict anxious symptomatology six months 





















































































































































































































































































































































































































































































































































































































































































































































































































































Table 7 (on page 72) presents a summary of the results on the 
influence of baseline psychosocial resources on non-somatic anxious 





The final chapter of this thesis discusses the results of the present study 
in relation to its objectives, specifically, exploring, across time, the: course of 
psychosocial resources; prevalence and course of subsyndromal depression 
and anxiety and course of depressive and anxious symptoms; and cross-
sectional and longitudinal associations between positive psychosocial 
resources and symptoms of anxiety and depression. This chapter will then 
delve into the clinical and research implications of the findings, as well as 
some caveats and limitations of the present study, before postulating future 
research directions and concluding this thesis. 
Overview of Findings 
This is the first study to examine the collective simultaneous influence 
of positive psychosocial resources such as hope, optimism, resilience, 
mindfulness, and spirituality on non-somatic symptoms of depression and 
anxiety across the first year in Asian patients’ diagnosed with cancer. It is also 
the first study to examine the course of these resources and subsyndromal 
depression and anxiety over time. Findings from the present study indicate 
that (1) psychosocial resources are significantly associated with depression 
and anxiety. Having controlled for baseline sociodemographic and medical 
variables, findings suggest that (3) psychosocial resources, and (4) symptoms, 
as well as subsyndromal, depression and anxiety, are stable across the first 
year. Finally, the present study findings also suggest that, of the various 
psychosocial resources and components, (5) spirituality and its aspects 
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(meaning/peace and faith) were consistently significant, independent, 
predictors influence levels of depressive and anxious symptoms across the 
first year of diagnosis in Asian cancer patients. 
Stability in the Course of Psychosocial Resources 
Few studies on cancer patients have examined the course of 
psychosocial resources over time, despite postulations that post-traumatic 
growth may be key in moderating patients’ emotional responses to the cancer 
journey (Carr & Steel, 2013). This is the first study that collectively looks at 
various positive psychosocial resources across the first year of a cancer 
diagnosis in Asian outpatients.  
Findings from two confirmatory sets of analyses from the present 
study suggest that the course of the five positive psychosocial resources (i.e., 
hope, optimism, resilience, mindfulness, and spirituality) remains constant 
across the first year of diagnosis after controlling for baseline 
sociodemographic and medical variables. These results are in support of 
theoretical conceptualisations of these psychosocial resources as innate 
dispositions or traits that rarely fluctuate without targeted intervention 
(Costantini et al., 2013).  
Hope, optimism, mindfulness, resilience, and spirituality can all be 
considered universal cognitive constructs and models of situational appraisals. 
Hope is the expectation of achieving a future good, regardless of the 
circumstances; optimism focuses on the quality of these expected outcomes. 
Individuals that are hopeful and optimistic may therefore find themselves 
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more likely to focusing their attention on positive, or drawing their attention 
away from the negative, aspects, threats, and crises of a cancer diagnosis. 
Resilience is the general ability to withstand and thrive in the face of adversity, 
even the threats associated with a cancer diagnosis. Mindfulness promotes 
moment-to-moment awareness and a non-judgement of experiences associated 
with the cancer, notwithstanding positive expectations of the outcome. 
Spirituality allows individuals to seek meaning from the cancer experience, 
and rely upon a transcendent dimension of existence for support. 
While these resources may be malleable as adolescents or young adults, 
in the present sample with a mean age of 48.75 years, these resources are 
likely to have already been established. Further, conceptualisations of these 
resources do not lend themselves to acting upon themselves in either an 
upward or downward spiral (e.g., being hopeful about a particular event does 
not lead one to be even more hopeful, or even less hopeful, or future events). 
These results are also in line with research on specific interventions targeting 
improvements of these constructs in Asian cancer patients, which have found 
that while there are post-treatment improvements, without booster sessions 
these improvements are not maintained and fall back to the pre-intervention 
levels of such automatic coping styles (e.g., Liao et al., 2014).  
Therefore, while it is understandable that the results of the present 
study find a general stability in the course of these resources over time, more 
recent research (e.g., Hou et al., 2010) has suggested that there are intra-
individual gains and losses in psychosocial resources that may be masked by 
examining group means and variances. This approach may be helpful in 
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identifying individual variations, but even in such studies a majority of the 
trajectories seem to suggest stability, with only one group of patients showing 
growth after having started out with impaired levels of resources. These 
studies have also not controlled for the multifarious associations of 
sociodemographic variables that may themselves predispose individuals to 
impaired levels of resources. As such, the findings from the present study 
suggest the stability in these resources. 
Stability in the Course of Depression and Anxiety 
Recent research on the course of depression and anxiety and its 
subsyndromal prevalence has been somewhat unclear, with most studies being 
done only in Western contexts. This present study represents one of the few 
attempts at investigating the prevalence of subsyndromal depression and 
anxiety in Asian cancer outpatients (based on locally-validated cut-offs), and 
the course of non-somatic symptoms of depression and anxiety across the first 
year in Asian cancer patients after controlling for all baseline 
sociodemographic and medical variables. Findings, in two separate 
confirmatory analyses, suggest that depression and anxiety are stable across 
time. 
High prevalence and stable course of subsyndromal depression 
and anxiety. Findings from the present study reveal that almost one in five 
suffer from persistent subsyndromal depression, and one in two participants 
has persistent subsyndromal anxiety across the year, similar to past research 
suggesting significantly elevated levels of distress in newly diagnosed patients 
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(Sheldon et al., 2008; van’t Spijker et al., 1997). Findings also suggest that at 
least one in three patients has subsyndromal levels of depression, and at least 
two in three patients has subsyndromal levels of anxiety over the first year, 
and these rates are stable. While these high levels fall within global estimates 
of depression (Mitchell et al., 2011; Pasquini & Biondi, 2007; Valentine, 
2011), they do not fall within the global estimates of anxiety (Mitchell et al., 
2011; Rashid, 2011; Steinman, 2009), which may be due to the daily 
fluctuations of anxiety that stem from other sociocultural or personality issues 
(Rashid, 2011).  
Regardless, these elevated levels of depression and anxiety also verify 
past results that the prevalence of these disorders in Asians are higher in 
cancer outpatients than in the general local population (Chong et al., 2012; 
Yang et al., 2013). These prevalence rates are also higher than those in a local 
cancer inpatient population (S. M. Tan et al., 2014) and those at first 
outpatient visit to the oncologist (H. A. Lim, Mahendran, Chua, et al., 2014). 
While there may be measurement differences, the present study used locally 
validated interview-based thresholds for caseness of depression and anxiety, 
which are arguably better representatives, and may thus have been more 
sensitive to subsyndromal levels of these disorders (especially anxiety) as 
compared to the international cut-offs (cf. Vodermaier & Millman, 2011).  
Stable course of non-somatic symptoms of depression and anxiety. 
Study findings also suggest that levels of non-somatic depressive and anxious 
symptoms were stable across time, which is from past research conducted in 
Western settings suggesting the transience of such emotional distress (e.g., 
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Saboonchi et al., 2014). This may potentially be due to the low utilisation of 
mental health services in Asian contexts (Chong et al., 2007; D.-Y. Han, Chen, 
Hwang, & Wei, 2006; B. S. K. Kim & Omizo, 2003; Kua, 2004) as compared 
to those in the West (Stafford et al., 2013), where oncology clinics focus 
primarily on physical, and less on the emotional, sequelæ of the disease 
treatment and progression (Grassi & Watson, 2012). It may, however, also be 
because other studies on the course of such symptomatology that note 
improvements or worsening symptoms did not control for multifarious 
associations of sociodemography and medical variables with depression and 
anxiety (Mahendran, Lim, Tan, Kua, et al., 2015).  
Recent research has suggested that such group level changes may be 
reductive and obscure heterogeneity in results (Dunn et al., 2011). Such 
research has posited that intra-individual trajectories of anxiety and depression 
may better elucidate variation in psychological distress (Bidstrup et al., 2015) 
and emotional adjustment (Donovan, Gonzalez, Small, Andrykowski, & 
Jacobsen, 2014) across significant periods (Henselmans et al., 2010) in the 
cancer journey even up to survivorship (Helgeson et al., 2004). While a recent 
study on Chinese outpatients with advanced breast cancer (N = 192) has 
suggested that there are four trajectories of depression and anxiety (W. W. T. 
Lam et al., 2013), almost four in five patients (77%) reported stable 
trajectories of anxiety and depression with the remaining classified as 
recovering. These results are also similar in other abovementioned studies on 
trajectories of depression and anxiety, few of which have controlled again for 
the multifarious associations of sociodemography and medical variables with 
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depression and anxiety (Mahendran, Lim, Tan, Kua, et al., 2015). Therefore, 
while it is important to go beyond the mean, it is of greater importance to note 
the stability of these elevated levels of depression and anxiety in Asian cancer 
outpatients.  
Relationships between Resources, Depression, and Anxiety 
Relatively fewer studies have examined the associations and influence 
of positive psychosocial resources like hope, optimism, resilience, 
mindfulness, and spirituality in Asian cancer patients despite postulations of 
their role in moderating emotional responses in the general Western 
populations (Carr & Steel, 2013). This is the first study that has examined the 
associations and predictive value of these resources simultaneously. 
Psychosocial resources are associated with non-somatic symptoms 
of depression and anxiety. Findings from the present study suggest 
significant associations between all the positive psychosocial resources and 
depression and anxiety in Asian cancer outpatients. In line with past research 
in the West and in Asia (Guan et al., 2009; Y. Han et al., 2013; Ho et al., 2003; 
Hou et al., 2010; Kang et al., 2008; Rajandram et al., 2011; Shimizu et al., 
2012; Uchitomi et al., 2003; Yang et al., 2014; Yuen et al., 2014), higher 
levels of hope are associated with fewer symptoms of depression and anxiety, 
accounting for 8–30% of the variance in depression and anxiety scores. 
Similarly, higher levels of optimism are also associated with depression and 
anxiety as previously found elsewhere in the West and in Asian cancer 
patients (Ha & Cho, 2014; W. W. T. Lam et al., 2013, 2012; Rajandram et al., 
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2011; Yang et al., 2014), accounting for 11–28% of the variance in depression 
and anxiety scores. As discussed earlier, these results are expected as 
hypothesised because more hopeful and optimistic individuals focus on 
positive outcomes and turn their attention away from negative outcomes; these 
outcomes in the cancer journey are often denoted by various milestones in 
treatment, or even in other domains not associated with the cancer, assisting 
with emotional adjustment to the disease. 
Also in line with past research in the West and in Asian oncology 
samples (J. I. Kim & Byeon, 2013; W. W. T. Lam et al., 2012; Min et al., 
2013; Tian & Hong, 2014), higher levels of resilience are associated with 
fewer non-somatic symptoms of depression and anxiety (or emotional distress), 
accounting for 10–32% of the variation in depression and anxiety scores. 
Understandably, and in line with the expected hypothesis, resilience buffers 
the emotional reaction to the cancer diagnosis across time. Similarly, higher 
levels of spirituality are associated with lower levels of depression and anxiety, 
accounting for 17–41% of depression and anxiety score variance. This result is 
also in line with the expected hypothesis suggesting that spiritual individuals 
have better ability to seek meaning from experience and rely upon a 
transcendent existence for support, and also past research in Asian oncology 
patients (H.-R. Lin & Bauer-Wu, 2003; Raja Lexshimi et al., 2014). This 
finding is, however, in contrast to other studies suggesting that the effect of 
spirituality in Asian ethnic cancer patients is the result of their immigrant 
status (J. Lim & Yi, 2009; Moadel & Harris, 2008; K.-Y. Wen et al., 2014). 
  
86 
Mindfulness, or the moment-to-moment awareness and a non-
judgement of experiences associated with the cancer, is also significantly 
associated with depression and anxiety over time, accounting for 14–23% of 
the variance in depression and anxiety scores. This is the first study in an 
Asian context to quantify the effect of mindfulness on depression and anxiety 
in Asian cancer patients, and this result is in line with the expected hypothesis 
and past research on the general associations between mindfulness and 
depression and anxiety in Western oncology patients (Eyles et al., 2014).  
Interesting, however, are the findings that suggest that not all aspects 
of mindfulness are associated significantly with depression and anxiety. In 
particular, without controlling for any sociodemographic or medical variables, 
the observing aspect of mindfulness, which quantifies how observant 
individuals are of their surroundings, bodily sensations, and feelings, is 
significantly related to only depression at the three-month follow-up, 
accounting for 6% of variance in depression scores. The non-judging aspect of 
mindfulness, which quantifies how non-judgemental individuals are of events, 
thoughts, or experiences, is significantly related to anxiety at baseline, 
accounting for 4% of the variance in anxiety scores. It is premature to 
postulate on the reasons behind findings because of the lack of research that 
has been done in general populations, and also because no in-depth analyses or 
follow-up qualitative interviews were not conducted. These results may 
provide some preliminary evidence as to the differential impact of the various 
aspects of mindfulness on depression and anxiety, and the need to focus on 
specific skills, or they may be chance findings that should first be replicated. 
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Psychosocial resources influence non-somatic symptoms of anxiety 
and depression. As seen earlier, each of the psychosocial resources is related 
to both depression and anxiety at the bivariate level, but no study has yet 
examined their collective relationships on depression and anxiety cross-
sectionally and longitudinally. This is the first study on oncology patients to 
identify which ones, amongst all the psychosocial resources, are more 
important in influencing depression and anxiety scores over and above 
sociodemographic and medical variables.  
Hope is important in influencing non-somatic symptoms of 
depression at baseline. Results suggest that hope is one of the more important 
psychosocial resources that have to be considered when seeking to ameliorate 
cancer patients’ depressive symptoms at baseline, or within the first three 
months post-diagnosis, where much of the focus is on beginning anticancer 
therapy. This is in line with results suggesting that hope better accounts for 
depression than does optimism in Asian contexts (Yang et al., 2014). Upon 
further investigation, it was determined that the pathways aspect of hope 
accounted for this influence. As suggested elsewhere (Chi, 2007), being able 
to conceptualise the means through which they can achieve their goals 
(whether cancer-related or as a result of such cancer-related crises) may 
potentially assist individuals in coping with the depressive symptoms because 
of the confidence that these matters can be taken care of regardless of the 
outcome of treatment  
Mindfulness is important in influencing non-somatic symptoms of 
anxiety. Results also suggest that being mindful is important in influencing 
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anxious symptoms at baseline. Specifically, being non-judgemental seems key 
to understanding the effect of mindfulness on baseline anxiety as well as 
anxiety three months later. Within the first six months, patients experience a 
range of emotional crises during anticancer therapy that may threaten to send 
them into an emotional spiral. The non-judgmental aspect of mindfulness may 
potentially allow patients to better tolerate the bodily sensations and regulate 
the emotional discomfort (Piet et al., 2012), which may also improve 
parasympathetic nervous system responses (Arch & Craske, 2006). In addition, 
the describing aspect of mindfulness at baseline also comes up as significant 
in predicting anxious symptoms three months post-baseline. Being able to 
describe thoughts and emotions without judgement may allow cancer patients 
more insight as to the emotions, and allow them to calmly reflect and 
appreciate their existence, quelling existential anxiety (Shennan et al., 2011).  
Faith is important in influencing non-somatic symptoms of 
depression. Findings from the present study also suggest that spirituality plays 
a crucial role in influencing depressive symptoms across the first year of 
diagnosis. Within the first three months post-diagnosis, counter-intuitively, 
higher levels of faith, or a more secure connection to a transcendental 
experience, are related to higher levels of depression. This may be explained 
by the response to the existential crisis that cancer brings. The threat and fear 
of death creates great anxiety that is often mitigated by finding meaning or 
peace in the situation; however, at times, especially for those hailing from a 
traditional Judeo-Christian religion whose somewhat ego-centric framework 
suggests that the higher being can act upon the present world, patients may 
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experience what is known as spiritual struggle (Peteet & Balboni, 2013; 
Schreiber, 2011).  
Spiritual struggle is a style of coping that involves apportioning blame 
to a higher being (i.e., ‘God’) or appraising the cancer diagnosis as 
punishment for a deed done in present life (Schreiber, 2011). While other 
religious traditions like Buddhism and Hinduism may also appraise cancer as 
punishment, this punishment is normally centred on the concept of karmic 
retribution for wrongdoings in the past life; to those of the Judeo-Christian 
faiths, the appraisal is that of a punishment for wrongdoings conducted by the 
individual in the present life. As such, and understandably especially at the 
first few months post-diagnosis, where individuals seek to make meaning, 
having more faith in a higher unknown power or being may lead to depressive 
symptoms. However, successfully struggling, and resolving this struggle, is 
key to better longitudinal outcomes (Wortmann, 2013): results reveal that 
higher levels of faith at baseline are the only significant component 
influencing the reduction in depressive symptomatology six months later. 
Greater faith, or a better connection with a transcendent existence (whatever 
the religion) seems to protect against depression. 
Meaning/peace is important in influencing non-somatic symptoms 
anxiety and depression. This may perhaps be also explained by results 
suggesting that finding meaning and peace in the cancer diagnosis (whether a 
result of the spiritual struggle) may lead to fewer symptoms of depression and 
anxiety at baseline and three months later. Past work on the meaning-making 
model (Davis, Nolen-Hoeksema, & Larson, 1998; Park, 2005, 2010) in cancer 
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patients and in Asian settings has suggested that traumatic experiences, such 
as a cancer diagnosis, may shatter core beliefs (e.g. that the world is a safe 
place) and goals (e.g. goal for security) and result in significant depression and 
anxiety (H. A. Lim, Park, & Slattery, 2012). Incorporating these new 
experiences into one’s worldview and mending these shattered assumptions 
lead to better meaning-making, which ultimately reduce such emotional 
sequelæ (H. A. Lim, Mahendran, Ng, Yee, & Teo, 2014; H. Y. Ng, Lim, & 
Park, 2013).  
These findings are also in line with past reviews suggesting the 
positive influence of spirituality on cancer patients (H.-R. Lin & Bauer-Wu, 
2003; Thuné-Boyle et al., 2006; A. Visser et al., 2010). Having found meaning 
and/peace may better influence coping in dealing not only with depression and 
anxiety as a result of spiritual struggle as well as existential crises of being 
(Peteet & Balboni, 2013) attributed both to the cancer diagnosis as well as to 
other aspects of an individual’s life.  
Clinical Implications 
Depression and anxiety have long been identified as global public 
health concerns (Das-Munshi et al., 2008; Ustün & Sartorius, 1993). 
Individuals afflicted with coexisting depression and/or anxiety, especially 
when coupled with a comorbid physical condition like cancer, place a high 
economic burden for society (Cassano & Fava, 2002) through their increasing 
dependence on state-financed healthcare (Moussavi et al., 2007).  
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The significant elevated levels of depression and anxiety in Asian 
cancer outpatients across the first year of diagnosis is therefore worrying. 
Findings from the present study potentially suggest that emotional sequelæ 
manifest themselves in the weeks following the diagnosis (and not at diagnosis 
itself; cf. H. A. Lim, Mahendran, Chua, et al., 2014), especially in ambulatory 
care patients who are not under the constant watchful eye of the medical team. 
Further, while it is heartening to note that patients do not deteriorate over the 
course of their first year of diagnosis, which is most crucial to survivorship, 
the high prevalence of subsyndromal depression and anxiety, as well as the 
significant proportions of patients with persistent subsyndromal sequelæ, 
suggest that these patients remain largely undetected in the cancer clinic 
across a year.  
Repeated reviews of patients’ emotional state may be necessary as the 
initial assessment of emotional reactions to diagnoses may not be a reliable 
predictor of long-term adjustment, in line with international recommendations 
for distress screening (Bultz & Johansen, 2011). However, while the local 
cancer clinic in Singapore has plans to implement clinic-wide distress 
screening and nurse-support (Mahendran, Tan, Lim, Chua, & Lim, 2014), 
psychosocial care for cancer patients in Asia is still presently too little, too late 
(Mahendran et al., 2013).  
While this may not only reflect the paucity of psychosocial services 
per se, despite the increased levels of such symptomatology, there is sparing 
evidence of psychosocial interventions in Asia (Uitterhoeve et al., 2004). A 
recent systematic review on psychosocial interventions to improve QOL and 
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emotional wellbeing in cancer patients (Galway et al., 2012) surfaced only one 
randomised controlled trial reporting an ineffective psychosocial intervention 
in Chinese women with gynaecological cancer (Y. M. Chan et al., 2005). 
Another systematic review on the management of depression and anxiety in 
cancer patients surfaced sixteen articles, none of which were on an Asian 
sample, or were from Asia (Jacobsen & Donovan, 2011).  
Recent calls for culturally-specific interventions in Asian contexts 
have thus highlighted that non-psychiatric clinicians (e.g. oncologists, nurse-
clinicians, counsellors, or psychologists) may be key in facilitating the 
reduction in levels of depression and anxiety (Mahendran, Lim, Tan, Chua, et 
al., 2015). In addition, psychosocial interventions for Asian cancer patients 
targeting the amelioration of depressive and anxious symptomatology need not 
necessarily be domain- or framework-specific nor administered in one-to-one 
sessions with psychiatrists (e.g., Liu et al., 2008). They should also remain 
brief (Mahendran, Tan, Ng, Lim, et al., 2015). Such interventions, which fall 
under the umbrella of brief integrative psychological therapy (BIPT; Feng, 
Cao, Zhang, Wee, & Kua, 2011; Kua, Goh, Cheong, & Wee, 2011), should 
integrate various components from existing modalities to improve therapeutic 
efficacy and better suit the needs of Asian patients.  
As such, it is thus recommended that clinics incorporate such programs 
to improve patients’ positive psychosocial resources (Fann, Ell, & Sharpe, 
2012), with holistic cancer care involving tiered psychosocial support nets by 
various providers (e.g., physicians, psychiatrists, psychologists, nurses, 
counsellors, etc.) offering various forms of evidence-based psychotherapeutic 
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modalities (such as cognitive behavioural therapy [CBT], group therapy, 
education, or counselling; Newell, Sanson-Fisher, & Savolainen, 2002). It is 
therefore necessary to develop culturally-specific, integrated, and brief 
interventions for Asian cancer patients (Clarke, 2010). Therapies should thus 
focus on improving positive psychosocial resources, values, and strengths 
(Grassi, 2013), such as hope, optimism, resilience, mindfulness, and 
spirituality (Carr & Steel, 2013), to aid patients through illness and recovery 
(Rotegård, Fagermoen, & Ruland, 2012; Spiegel, 2014). 
The present study highlights that these resources are relatively stable 
across time, which suggests that despite the trauma of the cancer journey, 
presumably premorbid levels of these resources are maintained throughout. 
While it is again heartening that there is no significant decline in resources, 
this may also suggest that such resources are less malleable and difficult to 
improve because of their automaticity. Past studies on such therapies in Asian 
oncology patients have suggested that these resources may potentially be 
improved, but without regular boosters, may not be sustained (Liao et al., 
2014). As such, given the already uphill battle psycho-oncologists are facing 
in Asian contexts, it may be useful to focus only on specific resources that are 
helpful for patients and allocate resources to booster sessions.  
Based on the present findings, the most important of these resources 
seem to be spirituality in Asian cancer patients, specifically developing 
meaning/peace and capitalising on patients’ spiritual frameworks for faith, be 
they religions, or philosophies, that may aid patients in meaning making. 
While some researchers have suggested looking at other aspects of wellbeing 
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such as equanimity (C. H. Y. Chan et al., 2014), in the present study, 
interventions that incorporate aspects of spirituality and perhaps even aspects 
of non-judging or observing aspects of mindfulness may potentially be the 
best form of such BIPT for Asian cancer patients and busy oncology clinics 
looking to minimise resource wastage. These interventions can be focused on 
capitalising on religious traditions, and can be carried out by religious leaders, 
or can be even conducted in secular contexts with people of diverse faith 
traditions. Helping cancer patients find a what, or a why, to live for will help 
them live through the how.  
Study Strengths and Limitations 
The present study has several important strengths. It used a diverse 
sample of cancer outpatients of Asian ethnicity that were diagnosed within 
three months (the existential period and key period for suicides, and when 
patients normally need assistance the most) and prospectively tracked them 
across the first year of their diagnosis at three-monthly time points. This 
sample was representative of the local Singapore cancer population in terms of 
demography and general medical variables (where comparable).  
In addition, patients who did not complete follow-up assessments 
(non-responders) were not significantly different on any demographic or 
medical variable as well as on any of the variable of interest; results from the 
longitudinal analyses are therefore also representative of the local cancer 
cohort. As such, selection bias was minimised, despite a lower than average 
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recruitment and response rate. Further, study participants could also 
participate at their convenience, minimising further loss. 
The present study is also the first study to have examined, 
systematically, the course of depression and anxiety, as well as psychosocial 
resources across time having controlled for all sociodemographic and medical 
variables. The present study also used more robust techniques (MANCOVAs) 
as opposed to other tests previously used in past studies that may have inflated 
the Type I error rate; in tandem with this is of course the potential issue of 
inflating Type II error rates. Results from the present study have therefore 
assisted in clarifying the literature, and provided fodder for the generation of 
future hypotheses in Asian and Western contexts. Findings also are 
significantly important in potentially developing future research or service 
interventions for Asian cancer patients. 
The present findings should, however, be interpreted in view of the 
study limitations. The first is the perennial issue of self-reports, which induce 
a recall bias, especially for measures of depression and anxiety that specify a 
time frame (last seven days). In tandem with this is also the issue of social 
desirability, especially on the psychosocial resources. It is however, important 
to note that patients were allowed to do this without any influence. 
Unfortunately, the FACIT-Sp-12 was a late addition and as such missed out 
earlier participants; however it is important to note that the final sample was 
still representative of the local cancer cohort. Patients were not interested in 
participating in the present study because they found such research onerous. 
This is characteristic of research conducted with the local cohort of cancer 
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patients receiving active treatment and within three months of their diagnosis 
(National Comprehensive Cancer Network, 2007) 
Controlling for a number of sociodemographic and medical variables 
may have also reduced the degrees of freedom and eventual power of the 
regression models, but it is important to note that collinearity thresholds were 
not violated, and results may have, at the very least, potentially 
underestimated the influence of these variables in Asian cancer patients. There 
may have, however, been changes in patients’ medical variables that were not 
captured in the present study; because of its heterogeneity, it was near 
impossible to compare treatment progression and quantify recovery across the 
various patients and cancer types. As such, subsequent management and 
treatment may have influenced these results.  
Underlying personality issues and social support, that was not 
controlled for in this exploratory study, may have confounded these results; 
however, past research has shown the significant associations between 
psychosocial resources and depression and anxiety over and above social 
support and other personality factors, so it is perhaps safe to assume that the 
preliminary results may provide future testable hypotheses. 
Future Directions for Research 
Regardless of these limitations, given the high prevalence of such non-
somatic symptomatology, future research should delve into exploring the 
anxious and depressive symptomatology that may manifest somatically and be 
overlooked as side effects of adjuvant cancer therapy. Forthcoming studies 
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should attempt to reify these findings on the course of depression and anxiety 
as well as psychosocial resources in other/minority Asian samples to ascertain 
the cross-cultural validity. 
In addition, more work, both quantitative or qualitative, is necessary to 
determine and confirm the influence of the various psychosocial resources on 
depression and anxiety and can be done in tandem with service development. 
Future research may also want to consider attempting to build more 
specialised models (or even investigate latent growth models) hypothesised 
from the present study that incorporate and control for other or personality or 
social factors in addition to sociodemographic and changing medical variables. 
This investigation can also involve more homogeneous samples that may 
reveal cancer-specific patterns that would assist the streamlining of resource 
allocation as well as service development.  
Conclusions 
The present study investigated the course of positive psychosocial 
variables such as hope, optimism, resilience, mindfulness, and spirituality, as 
well as non-somatic symptoms of depression and anxiety across the first year 
in Asian outpatients diagnosed with cancer. The present study also sought to 
reify the relationships between these positive psychosocial variables and 
symptoms of depression and anxiety, and explore the psychosocial 
components that would best account for the variance in these symptoms. 
While the body can turn upon itself in cancer, the mind can assist with these 
changes: findings from the present study suggested that the effect of Asian 
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cancer patients non-somatic symptoms of depression and anxiety across time 
may be best moderated by spirituality, specifically, making meaning of the 
situation and having faith in a higher transcendent existence. Allied health 
professionals for Asian cancer patients in busy outpatient clinics may 
potentially use secular elements of spirituality in brief interventions. While the 
course of psychosocial resources and depression and anxiety remained stable 
and did not decrease across the first year, the high levels and prevalence of 
subsyndromal depression and anxiety remain key issues that need to be 
addressed in Asian oncology clinics to provide early routine monitoring and 
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